<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39400904</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>CD015618</StartPage><MedlinePgn>CD015618</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD015618</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD015618</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diagnosing people with a SARS-CoV-2 infection played a critical role in managing the COVID-19 pandemic and remains a priority for the transition to long-term management of COVID-19. Initial shortages of extraction and reverse transcription polymerase chain reaction (RT-PCR) reagents impaired the desired upscaling of testing in many countries, which led to the search for alternatives to RNA extraction/purification and RT-PCR testing. Reference standard methods for diagnosing the presence of SARS-CoV-2 infection rely primarily on real-time reverse transcription-polymerase chain reaction (RT-PCR). Alternatives to RT-PCR could, if sufficiently accurate, have a positive impact by expanding the range of diagnostic tools available for the timely identification of people infected by SARS-CoV-2, access to testing and the use of resources.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the diagnostic accuracy of alternative (to RT-PCR assays) laboratory-based molecular tests for diagnosing SARS-CoV-2 infection.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the COVID-19 Open Access Project living evidence database from the University of Bern until 30 September 2020 and the WHO COVID-19 Research Database until 31 October 2022. We did not apply language restrictions.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">We included studies of people with suspected or known SARS-CoV-2 infection, or where tests were used to screen for infection, and studies evaluating commercially developed laboratory-based molecular tests for the diagnosis of SARS-CoV-2 infection considered as alternatives to RT-PCR testing. We also included all reference standards to define the presence or absence of SARS-CoV-2, including RT-PCR tests and established clinical diagnostic criteria.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two authors independently screened studies and resolved disagreements by discussing them with a third author. Two authors independently extracted data and assessed the risk of bias and applicability of the studies using the QUADAS-2 tool. We presented sensitivity and specificity, with 95% confidence intervals (CIs), for each test using paired forest plots and summarised results using average sensitivity and specificity using a bivariate random-effects meta-analysis. We illustrated the findings per index test category and assay brand compared to the WHO's acceptable sensitivity and specificity threshold for diagnosing SARS-CoV-2 infection using nucleic acid tests.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included data from 64 studies reporting 94 cohorts of participants and 105 index test evaluations, with 74,753 samples and 7517 confirmed SARS-CoV-2 cases. We did not identify any published or preprint reports of accuracy for a considerable number of commercially produced NAAT assays. Most cohorts were judged at unclear or high risk of bias in more than three QUADAS-2 domains. Around half of the cohorts were considered at high risk of selection bias because of recruitment based on COVID status. Three quarters of 94 cohorts were at high risk of bias in the reference standard domain because of reliance on a single RT-PCR result to determine the absence of SARS-CoV-2 infection or were at unclear risk of bias due to a lack of clarity about the time interval between the index test assessment and the reference standard, the number of missing results, or the absence of a participant flow diagram. For index tests categories with four or more evaluations and when summary estimations were possible, we found that: a) For RT-PCR assays designed to omit/adapt RNA extraction/purification, the average sensitivity was 95.1% (95% CI 91.1% to 97.3%), and the average specificity was 99.7% (95% CI 98.5% to 99.9%; based on 27 evaluations, 2834 samples and 1178 SARS-CoV-2 cases); b) For RT-LAMP assays, the average sensitivity was 88.4% (95% CI 83.1% to 92.2%), and the average specificity was 99.7% (95% CI 98.7% to 99.9%; 24 evaluations, 29,496 samples and 2255 SARS-CoV-2 cases); c) for TMA assays, the average sensitivity was 97.6% (95% CI 95.2% to 98.8%), and the average specificity was 99.4% (95% CI 94.9% to 99.9%; 14 evaluations, 2196 samples and 942 SARS-CoV-2 cases); d) for digital PCR assays, the average sensitivity was 98.5% (95% CI 95.2% to 99.5%), and the average specificity was 91.4% (95% CI 60.4% to 98.7%; five evaluations, 703 samples and 354 SARS-CoV-2 cases); e) for RT-LAMP assays omitting/adapting RNA extraction, the average sensitivity was 73.1% (95% CI 58.4% to 84%), and the average specificity was 100% (95% CI 98% to 100%; 24 evaluations, 14,342 samples and 1502 SARS-CoV-2 cases). Only two index test categories fulfil the WHO-acceptable sensitivity and specificity requirements for SARS-CoV-2 nucleic acid tests: RT-PCR assays designed to omit/adapt RNA extraction/purification and TMA assays. In addition, WHO-acceptable performance criteria were met for two assays out of 35 when tests were used according to manufacturer instructions. At 5% prevalence using a cohort of 1000 people suspected of SARS-CoV-2 infection, the positive predictive value of RT-PCR assays omitting/adapting RNA extraction/purification will be 94%, with three in 51 positive results being false positives, and around two missed cases. For TMA assays, the positive predictive value of RT-PCR assays will be 89%, with 6 in 55 positive results being false positives, and around one missed case.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Alternative laboratory-based molecular tests aim to enhance testing capacity in different ways, such as reducing the time, steps and resources needed to obtain valid results. Several index test technologies with these potential advantages have not been evaluated or have been assessed by only a few studies of limited methodological quality, so the performance of these kits was undetermined. Only two index test categories with enough evaluations for meta-analysis fulfil the WHO set of acceptable accuracy standards for SARS-CoV-2 nucleic acid tests: RT-PCR assays designed to omit/adapt RNA extraction/purification and TMA assays. These assays might prove to be suitable alternatives to RT-PCR for identifying people infected by SARS-CoV-2, especially when the alternative would be not having access to testing. However, these findings need to be interpreted and used with caution because of several limitations in the evidence, including reliance on retrospective samples without information about the symptom status of participants and the timing of assessment. No extrapolation of found accuracy data for these two alternatives to any test brands using the same techniques can be made as, for both groups, one test brand with high accuracy was overrepresented with 21/26 and 12/14 included studies, respectively. Although we used a comprehensive search and had broad eligibility criteria to include a wide range of tests that could be alternatives to RT-PCR methods, further research is needed to assess the performance of alternative COVID-19 tests and their role in pandemic management.</AbstractText><CopyrightInformation>Copyright © 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arevalo-Rodriguez</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS). CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evidence Production &amp; Methods Directorate, Cochrane, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateos-Haro</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral programme in Clinical Medicine and Public Health, Universidad de Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinnes</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciapponi</LastName><ForeName>Agustín</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Argentine Cochrane Centre, Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buitrago-Garcia</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario Mayor - Méderi. Universidad del Rosario, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennouna-Dalero</LastName><ForeName>Tayeb</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Preventive Medicine and Public Health Department, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roqué-Figuls</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iberoamerican Cochrane Centre, Institut de Recerca Sant Pau (IR SANT PAU), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Bruel</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academic Centre of General Practice, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Eije</LastName><ForeName>Karin J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Viroscience, ErasmusMC, University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emperador</LastName><ForeName>Devy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>FIND, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooft</LastName><ForeName>Lotty</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spijker</LastName><ForeName>René</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeflang</LastName><ForeName>Mariska Mg</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takwoingi</LastName><ForeName>Yemisi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Jonathan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="Y">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="Y">COVID-19 Nucleic Acid Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="Y">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005188" MajorTopicYN="N">False Negative Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Ingrid Arevalo‐Rodriguez: IAR has been an employee of the Cochrane Central Executive Team (Cochrane Response/Evidence, Production &amp; Methods Directorate) since 2021. Miriam Mateos: none known. Jacqueline Dinnes: none known. Clare Davenport: none known. Agustin Ciapponi: none known. Diana Buitrago‐Garcia: none known. Tayeb Bennouna Dalero: none known. Marta Roque‐Figuls: none known. Ann Van den Bruel: none known. Karin Jasmijn von Eije: KVE worked as a staff member till mid‐January 2021 for WHO; in that capacity, she has been involved in guidance on SARS‐CoV‐2 diagnostics. After that, she worked as a clinical virologist at the UMCG in Groningen and, in that capacity, was not directly involved in activities of WHO regarding guidance on molecular diagnostics for SARS‐CoV‐2; her contracted work did include work focused on the WHO SARS‐CoV‐2 laboratory network until August 2023. Since September 2023, she has worked at the Erasmus MC, University Medical Center, as a clinical virologist and has continued to perform contracted work, but not on WHO guidance on clinical molecular diagnostics for SARS‐CoV‐2 or the WHO SARS‐CoV‐2 laboratory network. Devy Emperador: DE is employed by FIND with funding from DFID and KFW. FIND is a global non‐for‐profit product development partnership and WHO Diagnostic Collaboration Centre. It is FIND's role to accelerate access to high‐quality diagnostic tools for low‐resource settings, and this is achieved by supporting both R&amp;D and access activities for a wide range of diseases, including COVID‐19. FIND has several clinical research projects to evaluate multiple new diagnostic tests against published Target Product Profiles that have been defined through consensus processes. These studies are for diagnostic products developed by private sector companies who provide access to know‐how, equipment/reagents, and contribute through unrestricted donations as per FIND policy and external SAC review. Lotty Hooft: none known. Mariska MG Leeflang: none known. René Spijker: the Dutch Cochrane Centre (DCC) has received grants for performing commissioned systematic reviews. The commissioner did not have any influence on the results of this work. Yemisi Takwoingi: none known. Jonathan J Deeks: JD has published or been quoted in opinion pieces in scientific publications, and in the mainstream and social media related to diagnostic testing. JD is a member of the Royal Statistical Society (RSS) COVID‐19 task force steering group and co‐chair of the RSS Diagnostic Test Advisory Group. He is a consultant adviser to the WHO Essential Diagnostic List. JD receives payment from the BMJ as their Chief Statistical advisor.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39400904</ArticleId><ArticleId IdType="pmc">PMC11472845</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD015618</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Alves 2021 {published data only}</Title><Reference><Citation>Alves PA, De Oliveira EG, Franco-Luiz APM, Almeida LT, Gonçalves AB, Borges IA, et al. Optimization and clinical validation of colorimetric reverse transcription loop-mediated isothermal amplification, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that Is robust to detect SARS-CoV-2 variants of concern. Frontiers in Microbiology 2021;12:713713. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637279</ArticleId><ArticleId IdType="pubmed">34867841</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern. medRxiv 2021;NA:1-38. [DOI: 10.1101/2021.05.26.21257488]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.21257488</ArticleId><ArticleId IdType="pmc">PMC8637279</ArticleId><ArticleId IdType="pubmed">34867841</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anastasiou 2021 (a) {published data only}</Title><Reference><Citation>Anastasiou OE, Holtkamp C, Schäfer M, Schön F, Eis-Hübinger AM, Krumbholz A. Fast detection of SARS-CoV-2 RNA directly from respiratory samples using a loop-mediated isothermal amplification (LAMP) test. Viruses 2021;13(5):801. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146783</ArticleId><ArticleId IdType="pubmed">33947014</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anastasiou 2021 (b) {published data only}</Title><Reference><Citation>Anastasiou OE, Holtkamp C, Schäfer M, Schön F, Eis-Hübinger AM, Krumbholz A. Fast detection of SARS-CoV-2 RNA directly from respiratory samples using a loop-mediated isothermal amplification (LAMP) test. Viruses 2021;13(5):801. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146783</ArticleId><ArticleId IdType="pubmed">33947014</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anastasiou 2021 (c) {published data only}</Title><Reference><Citation>Anastasiou OE, Holtkamp C, Schäfer M, Schön F, Eis-Hübinger AM, Krumbholz A. Fast detection of SARS-CoV-2 RNA directly from respiratory samples using a loop-mediated isothermal amplification (LAMP) test. Viruses 2021;13(5):801. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146783</ArticleId><ArticleId IdType="pubmed">33947014</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Antonara 2022 {published data only}</Title><Reference><Citation>Antonara S, Ozbolt P, Landon L, Fatica L, Pleasant T, Swickard J, et al. Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays. Diagnostic Microbiology and Infectious Disease 2022;102(1):115513. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324421</ArticleId><ArticleId IdType="pubmed">34649190</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Aoki 2022 {published data only}</Title><Reference><Citation>Aoki K, Nagashima M, Kashiwagi K, Chiba T, Sadamasu K, Ishii Y, et al. Study on the usefulness of Direct Saliva sample Collection (DiSC) by polyester swab. medRxiv [Preprint] 2022;NA:1-9. [DOI: 10.1101/2022.02.25.22271529]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.25.22271529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ar Goiuilh 2020 (a) {published data only}</Title><Reference><Citation>Ar Gouilh M, Cassier R, Maille E, Schanen C, Rocque LM, Vabret A. An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for point-of-care and diagnostic lab. medRxiv [Preprint] 2020;NA:1-9. [DOI: 10.1101/2020.09.25.20200956]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20200956</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ar Goiuilh 2020 (b) {published data only}</Title><Reference><Citation>Ar Gouilh M, Cassier R, Maille E, Schanen C, Rocque LM, Vabret A. An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for point-of-care and diagnostic lab. medRxiv [Preprint] 2020;NA:1-9. [DOI: 10.1101/2020.09.25.20200956]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20200956</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ar Goiuilh 2020 (c) {published data only}</Title><Reference><Citation>Ar Gouilh M, Cassier R, Maille E, Schanen C, Rocque LM, Vabret A. An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for point-of-care and diagnostic lab. medRxiv [Preprint] 2020;NA:1-9. [DOI: 10.1101/2020.09.25.20200956]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20200956</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ar Goiuilh 2020 (d) {published data only}</Title><Reference><Citation>Ar Gouilh M, Cassier R, Maille E, Schanen C, Rocque LM, Vabret A. An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for point-of-care and diagnostic lab. medRxiv [Preprint] 2020;NA:1-9. [DOI: 10.1101/2020.09.25.20200956]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20200956</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bordi 2020 (a) {published data only}</Title><Reference><Citation>Bordi L, Piralla A, Lalle E, Giardina F, Colavita F, Tallarita M, et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa COVID-19 direct assay. Journal of Clinical Virology 2020;128:104416. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198196</ArticleId><ArticleId IdType="pubmed">32388470</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bordi 2020 (b) {published data only}</Title><Reference><Citation>Bordi L, Piralla A, Lalle E, Giardina F, Colavita F, Tallarita M, et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa COVID-19 direct assay. Journal of Clinical Virology 2020;128:104416. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198196</ArticleId><ArticleId IdType="pubmed">32388470</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bordi 2020 (c) {published data only}</Title><Reference><Citation>Bordi L, Piralla A, Lalle E, Giardina F, Colavita F, Tallarita M, et al. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa COVID-19 direct assay. Journal of Clinical Virology 2020;128:104416. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198196</ArticleId><ArticleId IdType="pubmed">32388470</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brandsma 2020 {published data only}</Title><Reference><Citation>Brandsma E, Verhagen H, Van de Laar TJW, Claas ECJ, Cornelissen M, Van den Akker E. Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR. Journal of Infectious Diseases 2021;223(2):206-13. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665660</ArticleId><ArticleId IdType="pubmed">33535237</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandsma E, Verhagen H, Van de Laar TJW, Claas ECJ, Cornelissen M, Van den Akker E. Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR. medRxiv 2020;NA:1-14. [DOI: 10.1101/2020.07.27.20147249]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.27.20147249</ArticleId><ArticleId IdType="pmc">PMC7665660</ArticleId><ArticleId IdType="pubmed">33535237</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Broughton 2020 {published data only}</Title><Reference><Citation>Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nature Biotechnology 2020;38(7):870-4. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107629</ArticleId><ArticleId IdType="pubmed">32300245</ArticleId></ArticleIdList></Reference><Reference><Citation>Broughton JP, Deng X, Yu G, Fasching CL, Singh J, Streithorst J, et al. Rapid detection of 2019 novel coronavirus SARS-CoV-2 using a CRISPR-based DETECTR lateral flow assay. medRxiv 2020;NA:1-28. [DOI: 10.1101/2020.03.06.20032334]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.06.20032334</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown 2022 (a) {published data only}</Title><Reference><Citation>Brown B, O'Hara RW, Guiver M, Davies E, Birtles A, Farooq H, et al. Evaluation of a novel direct RT-LAMP assay for the detection of SARS-CoV-2 from saliva samples in asymptomatic individuals. Journal of Clinical Virology Plus 2022;2(2):100074. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942569</ArticleId><ArticleId IdType="pubmed">35345440</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown 2022 (b) {published data only}</Title><Reference><Citation>Brown B, O'Hara RW, Guiver M, Davies E, Birtles A, Farooq H, et al. Evaluation of a novel direct RT-LAMP assay for the detection of SARS-CoV-2 from saliva samples in asymptomatic individuals. Journal of Clinical Virology Plus 2022;2(2):100074. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942569</ArticleId><ArticleId IdType="pubmed">35345440</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown 2022 (c) {published data only}</Title><Reference><Citation>Brown B, O'Hara RW, Guiver M, Davies E, Birtles A, Farooq H, et al. Evaluation of a novel direct RT-LAMP assay for the detection of SARS-CoV-2 from saliva samples in asymptomatic individuals. Journal of Clinical Virology Plus 2022;2(2):100074. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942569</ArticleId><ArticleId IdType="pubmed">35345440</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown CA 2021 (a) {published data only}</Title><Reference><Citation>Brown CA, Amerson-Brown MH, Rahman A, Webb CR, Singh IR, Dunn JJ. Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients. Future Virology 2021;17(3):159-67. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734120</ArticleId><ArticleId IdType="pubmed">35027939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown CA 2021 (b) {published data only}</Title><Reference><Citation>Brown CA, Amerson-Brown MH, Rahman A, Webb CR, Singh IR, Dunn JJ. Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients. Future Virology 2021;17(3):159-67. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734120</ArticleId><ArticleId IdType="pubmed">35027939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown CA 2021 (c) {published data only}</Title><Reference><Citation>Brown CA, Amerson-Brown MH, Rahman A, Webb CR, Singh IR, Dunn JJ. Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients. Future Virology 2021;17(3):159-67. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734120</ArticleId><ArticleId IdType="pubmed">35027939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Brown CA 2021 (d) {published data only}</Title><Reference><Citation>Brown CA, Amerson-Brown MH, Rahman A, Webb CR, Singh IR, Dunn JJ. Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients. Future Virology 2021;17(3):159-67. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734120</ArticleId><ArticleId IdType="pubmed">35027939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cordes 2021 {published data only}</Title><Reference><Citation>Cordes AK, Rehrauer WM, Accola MA, Woelk B, Hilfrich B, Heim A. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion. medRxiv 2020;NA:1-25. [DOI: 10.1101/2020.08.31.20185074]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.31.20185074</ArticleId><ArticleId IdType="pubmed">33350484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes AK, Rehrauer WM, Accola MA, Wölk B, Hilfrich B, Heim A. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion. Journal of Medical Virology 2021;93(7):4438-45. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">33350484</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cradic 2020 {published data only}</Title><Reference><Citation>Cradic K, Lockhart M, Ozbolt P, Fatica L, Landon L, Lieber M, et al. Clinical evaluation and utilization of multiple molecular in vitro diagnostic assays for the detection of SARS-CoV-2. American Journal of Clinical Pathology 2020;154(2):201-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314271</ArticleId><ArticleId IdType="pubmed">32462195</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dang 2020 {published data only}</Title><Reference><Citation>Dang Y, Liu N, Tan C, Feng Yi, Yuan X, Fan D, et al. Comparison of qualitative and quantitative analyses of COVID-19 clinical samples. Clinica Chimica Acta 2020;510:613-6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446654</ArticleId><ArticleId IdType="pubmed">32858058</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Domnich 2021 {published data only}</Title><Reference><Citation>Domnich A, Orsi A, Panatto D, De Pace V, Ricucci V, Caligiuri P, et al. Comparative diagnostic performance of a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for the rapid detection of SARS-CoV-2. Pathogens 2021;10(12):1629. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8706056</ArticleId><ArticleId IdType="pubmed">34959584</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doria 2022 (a) {published data only}</Title><Reference><Citation>Doria G, Clemente C, Coelho E, Colaço J, Crespo R, Semikhodskii A, et al. An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour. International Journal of Infectious Diseases 2022;123:1-8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307284</ArticleId><ArticleId IdType="pubmed">35878801</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doria 2022 (b) {published data only}</Title><Reference><Citation>Doria G, Clemente C, Coelho E, Colaço J, Crespo R, Semikhodskii A, et al. An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour. International Journal of Infectious Diseases 2022;123:1-8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307284</ArticleId><ArticleId IdType="pubmed">35878801</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dossou 2022 (a) {published data only}</Title><Reference><Citation>Dossou NC, Gaubert I, Maille E, Morello R, Cassier R, Schanen C, et al. Use of LoopDeelab during the COVID-19 pandemic: an innovative device for field diagnosis. Viruses 2022;14(9):2062. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9505249</ArticleId><ArticleId IdType="pubmed">36146869</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dossou 2022 (b) {published data only}</Title><Reference><Citation>Dossou NC, Gaubert I, Maille E, Morello R, Cassier R, Schanen C, et al. Use of LoopDeelab during the COVID-19 pandemic: an innovative device for field diagnosis. Viruses 2022;14(9):2062. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9505249</ArticleId><ArticleId IdType="pubmed">36146869</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Eckel 2020 {published data only}</Title><Reference><Citation>Eckel F, Kusters F, Drossel B, Konert M, Mattes H, Schopf S. Variplex test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extraction. European Journal of Clinical Microbiology and Infectious Diseases 2020;39(12):2373-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367510</ArticleId><ArticleId IdType="pubmed">32681309</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egerer 2021 (a) {published data only}</Title><Reference><Citation>Egerer R, Edel B, Löffler B, Henke A, Rödel J. Performance of the RT-LAMP-based eazyplex® SARS-CoV-2 as a novel rapid diagnostic test. Journal of Clinical Virology 2021;138:104817. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015392</ArticleId><ArticleId IdType="pubmed">33836452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egerer 2021 (b) {published data only}</Title><Reference><Citation>Egerer R, Edel B, Löffler B, Henke A, Rödel J. Performance of the RT-LAMP-based eazyplex® SARS-CoV-2 as a novel rapid diagnostic test. Journal of Clinical Virology 2021;138:104817. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015392</ArticleId><ArticleId IdType="pubmed">33836452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Erdem 2022 {published data only}</Title><Reference><Citation>Erdem M, Andac-Ozketen A, Ozketen A, Karahan G, Tozluyurt A, Palaz F, et al. Clinical validation and the evaluation of a colorimetric SARS-CoV-2 RT-LAMP assay identify its robustness against RT-PCR (preprint). medRxiv [Preprint] 2022;NA:1-15. [DOI: 10.1101/2022.03.21.22271747]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.21.22271747</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdem M, Andaç-Özketen A, Özketen AÇ, Karahan G, Tozluyurt A, Palaz F, et al. Clinical validation and evaluation of a colorimetric SARS-CoV-2 RT-LAMP assay against RT-PCR. Infection Disease Clinical Microbiology 2023;5(2):136-43. [DOI: 10.36519/idcm.2023.210] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.36519/idcm.2023.210</ArticleId><ArticleId IdType="pmc">PMC10986683</ArticleId><ArticleId IdType="pubmed">38633012</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fernández‐Huerta 2022 {published data only}</Title><Reference><Citation>Fernández-Huerta M, Salmerón P, Hernández-Hermida Y, Andrés C, Niubó J, Calatayud L, et al. Multicenter clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing. Enfermedades Infecciosas y Microbiología Clínica 2022;NA:S2529-993X(23)00093-X. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841142</ArticleId><ArticleId IdType="pubmed">35185236</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fowler 2020 (a) {published data only}</Title><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection. Journal of Infection 2021;82(1):117-25. [DOI: 10.1016/j.jinf.2020.10.039] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7703389</ArticleId><ArticleId IdType="pubmed">33271166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 within nasopharyngeal and oropharyngeal swabs at Hampshire Hospitals NHS Foundation Trust. medRxiv [Preprint] 2020;NA:1-30. [DOI: 10.1101/2020.06.30.20142935]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.30.20142935</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fowler 2020 (b) {published data only}</Title><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection. Journal of Infection 2021;82(1):117-25. [DOI: 10.1016/j.jinf.2020.10.039] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7703389</ArticleId><ArticleId IdType="pubmed">33271166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 within nasopharyngeal and oropharyngeal swabs at Hampshire Hospitals NHS Foundation Trust. medRxiv [Preprint] 2020;NA:1-30. [DOI: 10.1101/2020.06.30.20142935]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.30.20142935</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fowler 2020 (c) {published data only}</Title><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection. Journal of Infection 2021;82(1):117-25. [DOI: 10.1016/j.jinf.2020.10.039] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7703389</ArticleId><ArticleId IdType="pubmed">33271166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler VL, Armson B, Gonzales JL, Wise EL, Howson ELA, Vincent-Mistiaen Z, et al. A reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 within nasopharyngeal and oropharyngeal swabs at Hampshire Hospitals NHS Foundation Trust. medRxiv [Preprint] 2020;NA:1-30. [DOI: 10.1101/2020.06.30.20142935]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.30.20142935</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Freedman 2022 {published data only}</Title><Reference><Citation>Freedman SB, Oberding LK, Kim K, Xie J, Berenger BM, Goulden R, et al. SARS-CoV-2 viral load quantification, clinical findings and outcomes in children seeking Emergency Department care: prospective cohort study. Pediatric Infectious Disease Journal 2022;41(7):566-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177124</ArticleId><ArticleId IdType="pubmed">35363652</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Freire‐Paspuel 2021 {published data only}</Title><Reference><Citation>Freire-Paspuel B, Garcia-Bereguiain MA. Low clinical performance of the Isopollo COVID-19 detection kit (M Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: a call for action against low quality products for developing countries. International Journal of Infectious Diseases 2021;104:303-5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834296</ArticleId><ArticleId IdType="pubmed">33434671</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ghosh 2022 {published data only}</Title><Reference><Citation>Ghosh P, Chowdhury R, Hossain ME, Hossain F, Miah M, Rashid MU, et al. Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings. International Journal of Infectious Diseases 2022;114:105-11. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572376</ArticleId><ArticleId IdType="pubmed">34758392</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gorzalski 2020 {published data only}</Title><Reference><Citation>Gorzalski AJ, Tian H, Laverdure C, Morzunov S, Verma SC, VanHooser S, et al. High-throughput transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2. Journal of Clinical Virology 2020;129:104501. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286273</ArticleId><ArticleId IdType="pubmed">32619959</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higashimoto 2020 {published data only}</Title><Reference><Citation>Higashimoto Y, Ihira M, Kawamura Y, Inaba M, Shirato K, Suzuki T, et al. Dry loop-mediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens. Fujita Medical Journal 2023;9(2):84-9. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10206895</ArticleId><ArticleId IdType="pubmed">37234399</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashimoto Y, Masaru I, Yoshiki K, Masato I, Kazuya S, Tadaki S, et al. Dry loop mediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens. medRxiv [Preprint] 2020;NA:1-26. [DOI: 10.1101/2020.09.29.20204297]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.29.20204297</ArticleId><ArticleId IdType="pmc">PMC10206895</ArticleId><ArticleId IdType="pubmed">37234399</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jerbi 2022 {published data only}</Title><Reference><Citation>Jerbi L, Azrad M, Peretz A. Evaluation of factors that affect the performance of COVID-19 molecular assays including presence of symptoms, number of detected genes and RNA extraction type. Molecular Diagnosis &amp; Therapy 2022;26(2):229-38. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784860</ArticleId><ArticleId IdType="pubmed">35072934</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kanwar 2021 {published data only}</Title><Reference><Citation>Kanwar N, Banerjee D, Sasidharan A, Abdulhamid A, Larson M, Lee B, et al. Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2. Diagnostic Microbiology and Infectious Disease 2021;101(4):115518. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343369</ArticleId><ArticleId IdType="pubmed">34481324</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kidd 2021 (a) {published data only}</Title><Reference><Citation>Kidd SP, Burns D, Armson B, Beggs AD, Howson ELA, Williams A, et al. Reverse-transcription loop-mediated isothermal amplification has high accuracy for detecting severe acute respiratory syndrome Coronavirus 2 in saliva and nasopharyngeal/oropharyngeal swabs from asymptomatic and symptomatic individuals. Journal of Molecular Diagnostics 2022;24(4):320-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806713</ArticleId><ArticleId IdType="pubmed">35121140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kidd 2021 (b) {published data only}</Title><Reference><Citation>Kidd SP, Burns D, Armson B, Beggs AD, Howson ELA, Williams A, et al. Reverse-transcription loop-mediated isothermal amplification has high accuracy for detecting severe acute respiratory syndrome Coronavirus 2 in saliva and nasopharyngeal/oropharyngeal swabs from asymptomatic and symptomatic individuals. Journal of Molecular Diagnostics 2022;24(4):320-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806713</ArticleId><ArticleId IdType="pubmed">35121140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kidd 2021 (c) {published data only}</Title><Reference><Citation>Kidd SP, Burns D, Armson B, Beggs AD, Howson ELA, Williams A, et al. Reverse-transcription loop-mediated isothermal amplification has high accuracy for detecting severe acute respiratory syndrome Coronavirus 2 in saliva and nasopharyngeal/oropharyngeal swabs from asymptomatic and symptomatic individuals. Journal of Molecular Diagnostics 2022;24(4):320-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806713</ArticleId><ArticleId IdType="pubmed">35121140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kidd 2021 (d) {published data only}</Title><Reference><Citation>Kidd SP, Burns D, Armson B, Beggs AD, Howson ELA, Williams A, et al. Reverse-transcription loop-mediated isothermal amplification has high accuracy for detecting severe acute respiratory syndrome Coronavirus 2 in saliva and nasopharyngeal/oropharyngeal swabs from asymptomatic and symptomatic individuals. Journal of Molecular Diagnostics 2022;24(4):320-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806713</ArticleId><ArticleId IdType="pubmed">35121140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kim 2021 {published data only}</Title><Reference><Citation>Kim KB, Choi H, Lee GD, Lee J, Lee S, Kim Y, et al. Analytical and clinical performance of Droplet Digital PCR in the detection and quantification of SARS-CoV-2. Molecular Diagnosis &amp; Therapy 2021;25(5):617-28. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316104</ArticleId><ArticleId IdType="pubmed">34319580</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kitagawa 2020 {published data only}</Title><Reference><Citation>Kitagawa Y, Orihara Y, Kawamura R, Imai K, Sakai J, Tarumoto N, et al. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. Journal of Clinical Virology 2020;58(9):e01438-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241399</ArticleId><ArticleId IdType="pubmed">32512376</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kitajima 2021 (a) {published data only}</Title><Reference><Citation>Kitajima H, Tamura Y, Yoshida H, Kinoshita H, Katsuta H, Matsui C, et al. Clinical COVID-19 diagnostic methods: comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR). Journal of Clinical Virology 2021;139:104813. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997201</ArticleId><ArticleId IdType="pubmed">33848785</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kitajima 2021 (b) {published data only}</Title><Reference><Citation>Kitajima H, Tamura Y, Yoshida H, Kinoshita H, Katsuta H, Matsui C, et al. Clinical COVID-19 diagnostic methods: comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR). Journal of Clinical Virology 2021;139:104813. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997201</ArticleId><ArticleId IdType="pubmed">33848785</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kuo 2021 {published data only}</Title><Reference><Citation>Kuo P, Realegeno S, Pride DT. Comparison of two nucleic acid amplification tests (NAATs) and two antigen tests for detection of SARS-CoV-2 from upper respiratory specimens. Journal of Clinical Virology Plus 2021;1(1):100011. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019354</ArticleId><ArticleId IdType="pubmed">35261999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kušnierová 2021 {published data only}</Title><Reference><Citation>Kušnierová P, Stejskal D, Švagera Z, Slepčanová H, Malurová M, Špulerová Z, et al. Comparison of two analytical methods for SARS-CoV-2 determination, RT-PCR vs. reverse transcription and loop-mediated isothermal amplification (RT-LAMP). Klinicka Biochemie a Metabolismus 2021;29(3):151-5. [EMBASE: covidwho-1820639]</Citation></Reference></ReferenceList><ReferenceList><Title>LeGoff 2021 (a) {published data only}</Title><Reference><Citation>LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, et al. Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Scientific Reports 2021;11(1):21126. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548486</ArticleId><ArticleId IdType="pubmed">34702867</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>LeGoff 2021 (b) {published data only}</Title><Reference><Citation>LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, et al. Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Scientific Reports 2021;11(1):21126. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548486</ArticleId><ArticleId IdType="pubmed">34702867</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lephart 2021 {published data only}</Title><Reference><Citation>Lephart PR, Bachman MA, LeBar W, McClellan S, Barron K, Schroeder L, et al. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type. Diagnostic Microbiology and Infectious Disease 2021;99(1):115200. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470790</ArticleId><ArticleId IdType="pubmed">32980807</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2022 {published data only}</Title><Reference><Citation>Li Z, Bruce JL, Cohen B, Cunningham CV, Jack WE, Kunin K, et al. Development and implementation of a simple and rapid extraction-free saliva SARS-CoV-2 RT-LAMP workflow for workplace surveillance. PLoS One 2022;17(5):e0268692. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135294</ArticleId><ArticleId IdType="pubmed">35617204</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lieberman 2020 {published data only}</Title><Reference><Citation>Lieberman JA, Pepper G, Naccache SN, Huang ML, Jerome KR, Greninger AL. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. Journal of Clinical Microbiology 2020;58(8):e00821-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383518</ArticleId><ArticleId IdType="pubmed">32350048</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lima 2020 {published data only}</Title><Reference><Citation>Lima A, Healer V, Vendrone E, Silbert S. Validation and comparison of a modified CDC assay with two commercially available assays for the detection of SARS-CoV-2 in respiratory specimen. bioRxiv [Preprint] 2020;NA:1-24. [DOI: 10.1101/2020.06.29.179192]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.29.179192</ArticleId><ArticleId IdType="pmc">PMC7657030</ArticleId><ArticleId IdType="pubmed">33220549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima A, Healer V, Vendrone E, Silbert S. Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens. Journal Clinical Virology 2020;133:104688. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657030</ArticleId><ArticleId IdType="pubmed">33220549</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liotti 2020 {published data only}</Title><Reference><Citation>Liotti FM, Menchinelli G, Marchetti S, Morandotti GA, Sanguinetti M, Posteraro B, et al. Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples. European Journal of Clinical Microbiology and Infectious Diseases 2021;40(2):269-77. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471581</ArticleId><ArticleId IdType="pubmed">32885293</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marino 2022 {published data only}</Title><Reference><Citation>Marino FE, Proffitt E, Joseph E, Manoharan A. A rapid, specific, extraction-less, and cost-effective RT-LAMP test for the detection of SARS-CoV-2 in clinical specimens. PLoS One 2022;17(4):e0266703. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9000105</ArticleId><ArticleId IdType="pubmed">35404944</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Milosevic 2022 {published data only}</Title><Reference><Citation>Milosevic D, Moyer AM, Majumdar R, Kipp BR, Yao JD. A reverse-transcription droplet digital PCR assay to detect and quantify SARS-CoV-2 RNA in upper respiratory tract specimens. Journal of Clinical Virology 2022;153:105216. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176174</ArticleId><ArticleId IdType="pubmed">35714461</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mizoguchi 2021 [A] {published data only}</Title><Reference><Citation>Mizoguchi M, Harada S, Okamoto K, Higurashi Y, Ikeda M, Moriya K. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples. PLoS One 2021;16(6):e0252757. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221491</ArticleId><ArticleId IdType="pubmed">34161355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mizoguchi 2021 [B] {published data only}</Title><Reference><Citation>Mizoguchi M, Harada S, Okamoto K, Higurashi Y, Ikeda M, Moriya K. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples. PLoS One 2021;16:e0252757. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221491</ArticleId><ArticleId IdType="pubmed">34161355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mizoguchi 2021 [C] {published data only}</Title><Reference><Citation>Mizoguchi M, Harada S, Okamoto K, Higurashi Y, Ikeda M, Moriya K. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples. PLoS One 2021;16(6):e0252757. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221491</ArticleId><ArticleId IdType="pubmed">34161355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mizoguchi 2021 [D] {published data only}</Title><Reference><Citation>Mizoguchi M, Harada S, Okamoto K, Higurashi Y, Ikeda M, Moriya K. Comparative performance and cycle threshold values of 10 nucleic acid amplification tests for SARS-CoV-2 on clinical samples. PLoS One 2021;16(6):e0252757. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221491</ArticleId><ArticleId IdType="pubmed">34161355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ogawa 2023 {published data only}</Title><Reference><Citation>Ogawa M, Sato M, Yamakami A, Hayasaka Y, Saya Y, Une K, et al. Diagnostic test property of transcription-reverse transcription concerted reaction reagent TRCReady® SARS-CoV-2 i using nasopharyngeal swab samples. Journal of Infection and Chemotherapy 2023;29(1):115-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9529250</ArticleId><ArticleId IdType="pubmed">36183991</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Österdahl 2020 {published data only}</Title><Reference><Citation>Österdahl MF, Lee KA, Lochlainn MN, Wilson S, Douthwaite S, Horsfall R, et al. Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR). BMC Infectious Diseases 2020;20(1):783. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574392</ArticleId><ArticleId IdType="pubmed">33081710</ArticleId></ArticleIdList></Reference><Reference><Citation>Österdahl MF, Lee KA, Ni Lochlainn M, Wilson S, Douthwaite S, Horsfall R, et al. Detecting SARS-CoV-2 at point of care: preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR. medRxiv 2020;NA:1-9. [DOI: 10.1101/2020.04.01.20047357]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.01.20047357</ArticleId><ArticleId IdType="pmc">PMC7574392</ArticleId><ArticleId IdType="pubmed">33081710</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Peto 2020 {published data only}</Title><Reference><Citation>Peto L, Rodger G, Carter DP, Osman KL, Yavuz M, Johnson K, et al. Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing. Journal of Clinical Microbiology 2021;59(6):e03271-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315953</ArticleId><ArticleId IdType="pubmed">33782112</ArticleId></ArticleIdList></Reference><Reference><Citation>Peto L, Rodger G, Carter DP, Osman KL, Yavuz M, Johnson K, et al. Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing. medRxiv 2020;NA:1-23. [DOI: 10.1101/2020.09.18.20195370]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.18.20195370</ArticleId><ArticleId IdType="pmc">PMC8315953</ArticleId><ArticleId IdType="pubmed">33782112</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pham 2020 {published data only}</Title><Reference><Citation>Pham J, Meyer S, Nguyen C, Williams A, Hunsicker M, McHardy I, et al. Performance characteristics of a high-throughput automated transcription-mediated amplification test for SARS-CoV-2 detection. Journal Clinical Microbiology 2020;58(10):e01669-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7512162</ArticleId><ArticleId IdType="pubmed">32727828</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Potter 2022 [A] {published data only}</Title><Reference><Citation>Potter RF, Ransom EM, Wallace MA, Johnson C, Kwon JH, Babcock HM, et al. Multiplatform assessment of saliva for SARS-CoV-2 molecular detection in symptomatic healthcare personnel and patients presenting to the Emergency Department. Journal of Applied Laboratory Medicine 2022;7(3):727-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499908</ArticleId><ArticleId IdType="pubmed">34491341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Potter 2022 [B] {published data only}</Title><Reference><Citation>Potter RF, Ransom EM, Wallace MA, Johnson C, Kwon JH, Babcock HM, et al. Multiplatform assessment of saliva for SARS-CoV-2 molecular detection in symptomatic healthcare personnel and patients presenting to the Emergency Department. Journal of Applied Laboratory Medicine 2022;7(3):727-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499908</ArticleId><ArticleId IdType="pubmed">34491341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Procop 2021 {published data only}</Title><Reference><Citation>Procop GW, Brock JE, Reineks EZ, Shrestha NK, Demkowicz R, Cook E, et al. A comparison of five SARS-CoV-2 molecular assays with clinical correlations. American Journal of Clinical Pathology 2021;155(1):69-78. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665304</ArticleId><ArticleId IdType="pubmed">33015712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Promlek 2022 {published data only}</Title><Reference><Citation>Promlek T, Thanunchai M, Phumisantiphong U, Hansirisathit T, Phuttanu C, Dongphooyao S, et al. Performance of colorimetric reverse transcription loop-mediated isothermal amplification as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand. International Journal of Infectious Diseases 2022;116:133-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709723</ArticleId><ArticleId IdType="pubmed">34958929</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ptasinska 2021 (a) {published data only}</Title><Reference><Citation>Ptasinska A, Whalley C, Bosworth A, Poxon C, Bryer C, Machin N, et al. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations. Clinical Microbiology and Infection 2021;27(9):1348.e1-1348.e7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064897</ArticleId><ArticleId IdType="pubmed">33901668</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ptasinska 2021 (b) {published data only}</Title><Reference><Citation>Ptasinska A, Whalley C, Bosworth A, Poxon C, Bryer C, Machin N, et al. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations. Clinical Microbiology and Infection 2021;27(9):1348.e1-1348.e7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064897</ArticleId><ArticleId IdType="pubmed">33901668</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ptasinska 2021 (c) {published data only}</Title><Reference><Citation>Ptasinska A, Whalley C, Bosworth A, Poxon C, Bryer C, Machin N, et al. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations. Clinical Microbiology and Infection 2021;27(9):1348.e1-1348.e7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064897</ArticleId><ArticleId IdType="pubmed">33901668</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Raju 2021 {published data only}</Title><Reference><Citation>Raju S, Anderson NW, Robinson E, Squires C, Wallace MA, Zhang R, et al. Comparison of 6 SARS-CoV-2 molecular methods and correlation with the cycle threshold distribution in clinical specimens. Journal of Applied Laboratory Medicine 2021;6(6):1452-62. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8436400</ArticleId><ArticleId IdType="pubmed">34289054</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rodel 2020 (a) {published data only}</Title><Reference><Citation>Rodel J, Egerer R, Suleyman A, Sommer-Schmid B, Baier M, Henke A, et al. Use of the variplex SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. Journal of Clinical Virology 2020;132:104616. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457909</ArticleId><ArticleId IdType="pubmed">32891938</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rodel 2020 (b) {published data only}</Title><Reference><Citation>Rodel J, Egerer R, Suleyman A, Sommer-Schmid B, Baier M, Henke A, et al. Use of the variplex SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. Journal of Clinical Virology 2020;132:104616. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457909</ArticleId><ArticleId IdType="pubmed">32891938</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rosenstierne 2021 (a) {published data only}</Title><Reference><Citation>Rosenstierne MW, Joshi S, Danielsen ET, Webb H, Luong DM, Bjerring J, et al. SARS-CoV-2 detection using reverse transcription strand invasion based amplification and a portable compact size instrument. Scientific Reports 2021;11(1):22214. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593107</ArticleId><ArticleId IdType="pubmed">34782681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rosenstierne 2021 (b) {published data only}</Title><Reference><Citation>Rosenstierne MW, Joshi S, Danielsen ET, Webb H, Luong DM, Bjerring J, et al. SARS-CoV-2 detection using reverse transcription strand invasion based amplification and a portable compact size instrument. Scientific Reports 2021;11(1):22214. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593107</ArticleId><ArticleId IdType="pubmed">34782681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rosenstierne 2021 (c) {published data only}</Title><Reference><Citation>Rosenstierne MW, Joshi S, Danielsen ET, Webb H, Luong DM, Bjerring J, et al. SARS-CoV-2 detection using reverse transcription strand invasion based amplification and a portable compact size instrument. Scientific Reports 2021;11(1):22214. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8593107</ArticleId><ArticleId IdType="pubmed">34782681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sauleda 2022 {published data only}</Title><Reference><Citation>Sauleda S, Palacios L, Brès V, Piñana M, Alonso-Hernandez L, Bes M, et al. Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system. Diagnostic Microbiology and Infectious Disease 2022;102(1):115560. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8464401</ArticleId><ArticleId IdType="pubmed">34688036</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schneider 2022 (a) {published data only}</Title><Reference><Citation>Schneider FS, Molina L, Picot MC, L'Helgoualch N, Espeut J, Champigneux P, et al. Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screening. Scientific Reports 2022;12(1):2843. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857239</ArticleId><ArticleId IdType="pubmed">35181680</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schneider 2022 (b) {published data only}</Title><Reference><Citation>Schneider FS, Molina L, Picot MC, L'Helgoualch N, Espeut J, Champigneux P, et al. Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screening. Scientific Reports 2022;12(1):2843. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857239</ArticleId><ArticleId IdType="pubmed">35181680</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shin 2022 {published data only}</Title><Reference><Citation>Shin W, Lee CJ, Lee YM, Choi YB, Mun S, Han K. Rapid identification of SARS-CoV-2 in the point-of-care using digital PCR-based Dr. PCR™ Di20K COVID-19 Detection Kit without viral RNA extraction. Genes &amp; Genomics 2022;44(5):617-28. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8965542</ArticleId><ArticleId IdType="pubmed">35353341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tanimoto 2022 {published data only}</Title><Reference><Citation>Tanimoto Y, Mori A, Miyamoto S, Ito E, Arikawa K, Iwamoto T. Comparison of RT-PCR, RT-LAMP, and antigen quantification assays for the detection of SARS-CoV-2. Japanese Journal of Infectious Diseases 2022;75(3):249-53. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">34588370</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tibbetts 2020 (a) {published data only}</Title><Reference><Citation>Tibbetts R, Callahan K, Rofoo K, Zarbo RJ, Samuel L. Comparison of the NeuMoDX, Diasorin Simplexa, Cepheid and Roche CDC SARS-CoV 2 EUA assays using nasopharyngeal/nasal swabs in universal transport media (UTM) and sputum and tracheal aspirates. bioRxiv [Preprint] 2020;NA:1-16. [DOI: 10.1101/2020.05.26.118190]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.26.118190</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tibbetts 2020 (b) {published data only}</Title><Reference><Citation>Tibbetts R, Callahan K, Rofoo K, Zarbo RJ, Samuel L. Comparison of the NeuMoDX, Diasorin Simplexa, Cepheid and Roche CDC SARS-CoV 2 EUA assays using nasopharyngeal/nasal swabs in universal transport media (UTM) and sputum and tracheal aspirates. bioRxiv [Preprint] 2020;NA:1-16. [DOI: 10.1101/2020.05.26.118190]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.26.118190</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Trémeaux 2020 (a) {published data only}</Title><Reference><Citation>Trémeaux P, Lhomme S, Abravanel F, Raymond S, Mengelle C, Mansuy JM, et al. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. Journal of Clinical Virology 2020;129:104541. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336924</ArticleId><ArticleId IdType="pubmed">32659713</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Trémeaux 2020 (b) {published data only}</Title><Reference><Citation>Trémeaux P, Lhomme S, Abravanel F, Raymond S, Mengelle C, Mansuy JM. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. Journal of Clinical Virology 2020;129:104541. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336924</ArticleId><ArticleId IdType="pubmed">32659713</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wanney 2022 {published data only}</Title><Reference><Citation>Wanney J, Lüsebrink J, Spölgen G, Demuth S, Schildgen V, Schildgen O. Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR assay with commercial LAMP assay using throat washes in health care staff testing. Journal of Clinical Virology Plus 2022;2(3):100088. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159961</ArticleId><ArticleId IdType="pubmed">35669098</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Watanabe 2022 {published data only}</Title><Reference><Citation>Watanabe N, Watari T, Otsuka Y. Quality control of loop-mediated isothermal amplification (LAMP) using external control: detection of SARS-CoV-2 using nasopharyngeal specimens. Access Microbiology [Preprint] 2022;NA:1-21. [DOI: 10.1099/acmi.0.000477.v1]</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/acmi.0.000477.v1</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xu 2021 {published data only}</Title><Reference><Citation>Xu J, Kirtek T, Xu Y, Zheng H, Yao H, Ostman E, et al. Digital droplet PCR for SARS-CoV-2 resolves borderline cases. American Journal of Clinical Pathology 2021;155(6):815-22. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083587</ArticleId><ArticleId IdType="pubmed">33822853</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhen 2020 {published data only}</Title><Reference><Citation>Zhen W, Manji R, Smith E, Berry GJ. Comparison of four molecular in vitro diagnostic assays for the detection of SARS-CoV-2 in nasopharyngeal specimens. Journal of Clinical Microbiology 2020;58(8):e00743-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383517</ArticleId><ArticleId IdType="pubmed">32341143</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Abasiyanik 2021 {published data only}</Title><Reference><Citation>Abasiyanik MF, Flood B, Lin J, Ozcan S, Rouhani SJ, Pyzer A, et al. Sensitive detection and quantification of SARS-CoV-2 in saliva. Scientific Reports 2021;11(1):12425. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8203799</ArticleId><ArticleId IdType="pubmed">34127708</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Akimkin 2022 {published data only}</Title><Reference><Citation>Akimkin VG, Petrov VV, Krasovitov KV, Borisova NI, Kotov IA, Rodionova EN, et al. Molecular methods for diagnosing novel coronavirus infection: comparison of loop-mediated isothermal amplification and polymerase chain reaction. Voprosy Virusologii 2022;66(6):417-24. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">35019248</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Alekseenko 2021 {published data only}</Title><Reference><Citation>Alekseenko A, Barrett D, Pareja-Sanchez Y, Howard R, Strandback E, Ampah-Korsah H, et al. Detection of SARS-CoV-2 using non-commercial RT-LAMP regents and raw samples. Scientific Reports 2021;11(1):1820. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7815738</ArticleId><ArticleId IdType="pubmed">33469065</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ali 2020 {published data only}</Title><Reference><Citation>Ali Z, Aman R, Mahas A, Gundra S, Tehseen M, Marsic T, et al. ISCAN: an RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Research 2020;288:198129. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434412</ArticleId><ArticleId IdType="pubmed">32822689</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anahtar 2020 {published data only}</Title><Reference><Citation>Anahtar MN, McGrath GEG, Rabe BA, Tanner NA, White BA, Lennerz JKM, et al. Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification. Open Forum Infectious Diseases 2020;8(2):1-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798487</ArticleId><ArticleId IdType="pubmed">34853795</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Artik 2022 {published data only}</Title><Reference><Citation>Artik Y, Coşğun AB, Cesur NP, Hızel N, Uyar Y, Sur H, et al. Comparison of COVID-19 laboratory diagnosis by commercial kits: effectivity of RT-PCR to the RT-LAMP. Journal of Medical Virology 2022;94(5):1998-2007. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015626</ArticleId><ArticleId IdType="pubmed">34997587</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Assennato 2020 {published data only}</Title><Reference><Citation>Assennato SM, Ritchie AV, Nadala C, Goel N, Tie C, Nadala LM, et al. Performance evaluation of the SAMBA II SARS-CoV-2 test for point-of-care detection of SARS-CoV-2. Journal of Clinical Microbiology 2020;59(1):e01262-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771448</ArticleId><ArticleId IdType="pubmed">33051242</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Avetyan 2020 {published data only}</Title><Reference><Citation>Avetyan D, Chavushyan A, Ghazaryan H, Melkonyan A, Stepanyan A, Zakharyan R, et al. SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic. medRxiv 2020;NA:1-25. [DOI: 10.1101/2020.09.10.20191189]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.10.20191189</ArticleId><ArticleId IdType="pmc">PMC8175123</ArticleId><ArticleId IdType="pubmed">34091213</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baba 2021 {published data only}</Title><Reference><Citation>Baba MM, Bitew M, Fokam J, Lelo EA, Ahidjo A, Asmamaw K, et al. Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: a multicenter prospective clinical evaluation in sub-Saharan Africa. EClinicalMedicine 2021;40:101101. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401528</ArticleId><ArticleId IdType="pubmed">34476394</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baek 2020 {published data only}</Title><Reference><Citation>Baek YH, Um J, Antigua KJC, Park JH, Kim Y, Oh S, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerging Microbes &amp; Infections 2020;9(1):998-1007. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301696</ArticleId><ArticleId IdType="pubmed">32306853</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Behrmann 2020 {published data only}</Title><Reference><Citation>Behrmann O, Bachmann I, Spiegel M, Schramm M, Abd El Wahed A, Dobler G, et al. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an Exo Probe with an internally linked quencher (Exo-IQ). Clinical Chemistry 2020;66(8):1047-54. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239256</ArticleId><ArticleId IdType="pubmed">32384153</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ben‐Assa 2020 {published data only}</Title><Reference><Citation>Ben-Assa N, Naddaf R, Gefen T, Capucha T, Hajjo H, Mandelbaum N, et al. Direct on-the-spot detection of SARS-CoV-2 in patients. Experimental Biology and Medicine 2020;245(14):1187-93. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385438</ArticleId><ArticleId IdType="pubmed">32668983</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bhoyar 2021 {published data only}</Title><Reference><Citation>Bhoyar RC, Jain A, Sehgal P, Divakar MK, Sharma D, Imran M, et al. High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing. PLoS One 2021;16(2):e0247115. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7888613</ArticleId><ArticleId IdType="pubmed">33596239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bloom 2020 {published data only}</Title><Reference><Citation>Bloom JS, Jones EM, Gasperini M, Lubock NB, Sathe L, Munugala C, et al. Swab-Seq: a high-throughput platform for massively scaled up SARS-CoV-2 testing. medRxiv 2020;NA:1-58. [DOI: 10.1101/2020.08.04.20167874]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.04.20167874</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Buck 2020 {published data only}</Title><Reference><Citation>Buck MD, Poirier EZ, Cardoso A, Frederico B, Canton J, Barrell S, et al. Standard operating procedures for SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay. medRxiv 2020;NA:1-28. [PMID: 10.1101/2020.06.29.20142430v1]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.29.20142430v1</ArticleId><ArticleId IdType="pmc">PMC8170534</ArticleId><ArticleId IdType="pubmed">34095506</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Butler 2020 {published data only}</Title><Reference><Citation>Butler DJ, Mozsary C, Meydan C, Danko D, Foox J, Rosiene J, et al. Shotgun transcriptome and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. bioRxiv 2020;NA:1-50. [DOI: 10.1101/2020.04.20.048066]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.20.048066</ArticleId><ArticleId IdType="pmc">PMC7954844</ArticleId><ArticleId IdType="pubmed">33712587</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Butt 2020 {published data only}</Title><Reference><Citation>Butt AM, Siddique S, An X, Tong Y. Development of a dual-gene loop-mediated isothermal amplification (LAMP) detection assay for SARS-CoV-2: a preliminary study. medRxiv 2020;NA:1-11. [DOI: 10.1101/2020.04.08.20056986]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.08.20056986</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cassinari 2021 {published data only}</Title><Reference><Citation>Cassinari K, Alessandri-Gradt E, Chambon P, Charbonnier F, Gracias S, Beaussire L, et al. Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples. Clinical Chemistry 2021;67(5):736-41. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799276</ArticleId><ArticleId IdType="pubmed">33331864</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chow 2020 {published data only}</Title><Reference><Citation>Chow FW, Chan TT, Tam AR, Zhao S, Yao W, Fung J, et al. A rapid, simple, inexpensive, and mobile colorimetric assay COVID-19-LAMP for mass on-site screening of COVID-19. International Journal of Molecular Sciences 2020;21(15):5380. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7432162</ArticleId><ArticleId IdType="pubmed">32751106</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Collier 2020 {published data only}</Title><Reference><Citation>Collier DA, Assennato SM, Warne B, Sithole N, Sharrocks K, Ritchie A, et al. Point of care nucleic acid testing for SARS-CoV-2 in hospitalized patients: a clinical validation trial and implementation study. Cell Reports Medicine 2020;1(5):100062. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362826</ArticleId><ArticleId IdType="pubmed">32838340</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dao 2020 {published data only}</Title><Reference><Citation>Dao Thi VL, Herbst K, Boerner K, Meurer M, Kremer LPM, Kirrmaier D, et al. Screening for SARS-CoV-2 infections with colorimetric RT-LAMP and LAMP sequencing. medRxiv 2020;NA:1-28. [DOI: 10.1101/2020.05.05.20092288]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.05.20092288</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davda 2020 {published data only}</Title><Reference><Citation>Davda JN, Frank K, Prakash S, Purohit G, Vijayashankar DP, Vedagiri D, et al. An inexpensive RT-PCR endpoint diagnostic assay for SARS-CoV-2 using nested PCR: direct assessment of detection efficiency of RT-qPCR tests and suitability for surveillance. bioRxiv 2020;NA:1-21. [DOI: 10.1101/2020.06.08.139477]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.08.139477</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deiana 2020 {published data only}</Title><Reference><Citation>Deiana M, Mori A, Piubelli C, Scarso S, Favarato M, Pomari E. Assessment of the direct quantitation of SARS-CoV-2 by droplet digital PCR. Scientific Reports 2020;10(1):18764. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599326</ArticleId><ArticleId IdType="pubmed">33127953</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>De Puig 2021 {published data only}</Title><Reference><Citation>De Puig H, Lee RA, Najjar D, Tan X, Soeknsen LR, Angenent-Mari NM, et al. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Science Advances 2021;7(eabh2944):1-11. [DOI: 10.1126/sciadv.abh2944]</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh2944</ArticleId><ArticleId IdType="pmc">PMC8346217</ArticleId><ArticleId IdType="pubmed">34362739</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Desai 2021 {published data only}</Title><Reference><Citation>Desai KT, Alfaro K, Mendoza L, Faron M, Mesich B, Maza M, et al. Multisite clinical validation of isothermal amplification-based SARS-CoV-2 detection assays using different sampling strategies. Microbiology Spectrum 2021;9(2):e0084621. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528118</ArticleId><ArticleId IdType="pubmed">34668736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dewhurst 2022 {published data only}</Title><Reference><Citation>Dewhurst RE, Heinrich T, Watt P, Ostergaard P, Marimon JM, Moreira M, et al. Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance. Scientific Reports 2022;12(1):5936. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990279</ArticleId><ArticleId IdType="pubmed">35395856</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dierks 2021 {published data only}</Title><Reference><Citation>Dierks S, Bader O, Schwanbeck J, Groß U, Weig MS, Mese K, et al. Diagnosing SARS-CoV-2 with antigen testing, transcription-mediated amplification and real-time PCR. Journal of Clinical Medicine 2021;10(11):2404. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8199284</ArticleId><ArticleId IdType="pubmed">34072381</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dimke 2021 {published data only}</Title><Reference><Citation>Dimke H, Larsen SL, Skov MN, Larsen H, Hartmeyer GN, Moeller JB. Phenol-chloroform-based RNA purification for detection of SARS-CoV-2 by RT-qPCR: comparison with automated systems. PLoS One 2021;16(2):e0247524. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904160</ArticleId><ArticleId IdType="pubmed">33626071</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ding 2020 {published data only}</Title><Reference><Citation>Ding X, Yin K, Li Z, Lalla RV, Ballesteros E, Sfeir MM, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nature Communications 2020;11(1):4711. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7501862</ArticleId><ArticleId IdType="pubmed">32948757</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Donato 2021 {published data only}</Title><Reference><Citation>Donato LJ, Trivedi VA, Stransky AM, Misra A, Pritt BS, Binnicker MJ, et al. Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center. Diagnostic Microbiology and Infectious Disease 2021;100(1):115307. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785428</ArticleId><ArticleId IdType="pubmed">33571863</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fasching 2022 {published data only}</Title><Reference><Citation>Fasching CL, Servellita V, McKay B, Nagesh V, Broughton JP, Sotomayor-Gonzalez A, et al. COVID-19 variant detection with a high-fidelity CRISPR-Cas12 enzyme. Journal of Clinical Microbiology 2022;60(7):e0026122. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297821</ArticleId><ArticleId IdType="pubmed">35766492</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fernández‐Pittol 2020 {published data only}</Title><Reference><Citation>Fernández-Pittol M, Hurtado JC, Moreno-García E, Rubio E, Navarro M, Valiente M, et al. Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19. bioRxiv 2020;NA:1-9. [DOI: 10.1101/2020.06.25.172734]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.25.172734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Figueiredo 2022 {published data only}</Title><Reference><Citation>Figueiredo D, Cascalheira A, Goncalves J. Rapid, multiplex detection of SARS-CoV-2 using isothermal amplification coupled with CRISPR-Cas12a. Scientific Reports 2022;NA:1-21. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9842216</ArticleId><ArticleId IdType="pubmed">36646742</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guan 2021 {published data only}</Title><Reference><Citation>Guan B, Frank KM, Maldonado JO, Beach M, Pelayo E, Warner BM, et al. Sensitive extraction-free SARS-CoV-2 RNA virus detection using a novel RNA preparation method. medRxiv 2021;NA:1-34. [DOI: 10.1101/2021.01.29.21250790]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.29.21250790</ArticleId><ArticleId IdType="pmc">PMC8349732</ArticleId><ArticleId IdType="pubmed">34396082</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guruceaga 2020 {published data only}</Title><Reference><Citation>Guruceaga X, Sierra A, Marino D, Santin I, Nieto-Garai JA, Bilbao JR, et al. Fast SARS-CoV-2 detection protocol based on RNA precipitation and RT-qPCR in nasopharyngeal swab samples. medRxiv 2020;NA:1-22. [DOI: 10.1101/2020.04.26.20081307]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.26.20081307</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Haq 2020 {published data only}</Title><Reference><Citation>Haq F, Sharif S, Khurshid A, Shabbir I, Salman M, Badar N, et al. Development optimization and validation of RT-LAMP based COVID-19 facility in Pakistan. bioRxiv 2020;NA:1-14. [PMID: 10.1101/2020.05.29.124123]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.29.124123</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hou 2020 {published data only}</Title><Reference><Citation>Hou T, Zeng W, Yang M, Chen W, Ren L, Ai J, et al. Development and evaluation of a CRISPR-based diagnostic for 2019-novel coronavirus. PLoS Pathogens 2020;16(8):e1008705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7451577</ArticleId><ArticleId IdType="pubmed">32853291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hu 2020 {published data only}</Title><Reference><Citation>Hu X, Deng Q, Li J, Chen J, Wang Z, Zhang X, et al. Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection. mSphere 2020;5(4):e00808-e00820. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449630</ArticleId><ArticleId IdType="pubmed">32848011</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang W 2020 {published data only}</Title><Reference><Citation>Huang W, Yu L, Wen D, Wei D, Sun Y, Zhao H, et al. A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection. EBioMedicine 2020;61:103036. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544594</ArticleId><ArticleId IdType="pubmed">33045467</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang WE 2020 {published data only}</Title><Reference><Citation>Huang WE, Lim B, Hsu CC, Xiong D, Wu W, Yu Y, et al. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Microbial Biotechnology 2020;13(4):950-61. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264870</ArticleId><ArticleId IdType="pubmed">32333644</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huang Z 2020 {published data only}</Title><Reference><Citation>Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, et al. Ultra-sensitive and high-throughput CRISPR-powered COVID-19 diagnosis. Biosensors and Bioelectronics 2020;15(164):112316. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245202</ArticleId><ArticleId IdType="pubmed">32553350</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Iqbal 2022 {published data only}</Title><Reference><Citation>Iqbal BN, Arunasalam S, Divarathna MVM, Jabeer A, Sirisena P, Senaratne T, et al. Diagnostic utility and validation of a newly developed real time loop mediated isothermal amplification method for the detection of SARS CoV-2 infection. Journal of Clinical Virology Plus 2022;2(3):100081. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9069985</ArticleId><ArticleId IdType="pubmed">35540180</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Israeli 2020 {published data only}</Title><Reference><Citation>Israeli O, Beth-Din A, Paran N, Stein D, Lazar S, Weiss S, et al. Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction. bioRxiv 2020;NA:1-6. [DOI: 10.1101/2020.06.10.144196]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.10.144196</ArticleId><ArticleId IdType="pmc">PMC7416699</ArticleId><ArticleId IdType="pubmed">32791207</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jacobson 2022 {published data only}</Title><Reference><Citation>Jacobson M, Hart C, Huen W, Suarez Guardado G, Villanueva A, Whitman J, et al. A rapid nucleic-acid-amplification-test-based, conditional-release-to-work policy for health care personnel with symptoms consistent with COVID-19. Journal of Occupational and Environmental Medicine 2022;65(2):125-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9897112</ArticleId><ArticleId IdType="pubmed">36240750</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Joung 2020 {published data only}</Title><Reference><Citation>Joung J, Ladha A, Saito M, Kim NG, Woolley AE, Segel M, et al. Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing. New England Journal of Medicine 2020;383(15):1492-4. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510942</ArticleId><ArticleId IdType="pubmed">32937062</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Karino 2021 {published data only}</Title><Reference><Citation>Karino M, Harada M, Yamada C, Fukuoka K, Sugo M, Hanada H, et al. Evaluation of the efficacy of LAMP-based SARS-CoV-2 detection with simple RNA extraction from nasopharyngeal swabs: a prospective observational study. PLoS One 2021;16(12):e0260732. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670695</ArticleId><ArticleId IdType="pubmed">34905576</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kiran 2020 {published data only}</Title><Reference><Citation>Kiran U, Gokulan CG, Kuncha SK, Vedagiri D, Tallapaka KB, Mishra RK, et al. Improved and simplified diagnosis of Covid-19 using TE extraction from dry swabs. bioRxiv 2020;NA:1-13. [DOI: 10.1101/2020.05.31.126342]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.31.126342</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Klein 2020 {published data only}</Title><Reference><Citation>Klein S, Muller TG, Khalid D, Sonntag-Buck V, Heuser AM, Glass B, et al. SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP. Viruses 2020;12(8):863. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472728</ArticleId><ArticleId IdType="pubmed">32784757</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kuiper 2020 {published data only}</Title><Reference><Citation>Kuiper JWP, Baade T, Kremer M, Kranaster R, Irmisch L, Schuchmann M, et al. Detection of SARS-CoV-2 from raw patient samples by coupled high temperature reverse transcription and amplification. medRxiv 2020;NA:1-25. [DOI: 10.1101/2020.05.19.20103150]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.19.20103150</ArticleId><ArticleId IdType="pmc">PMC7605687</ArticleId><ArticleId IdType="pubmed">33137168</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>L'Helgouach 2020 {published data only}</Title><Reference><Citation>L'Helgouach N, Champigneux P, Santos-Schneider F, Molina L, Espeut J, Alali M, et al. EasyCOV: LAMP based rapid detection of SARS-CoV-2 in saliva. medRxiv 2020;NA:1-14. [DOI: 10.1101/2020.05.30.20117291]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.30.20117291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lamb 2020 {published data only}</Title><Reference><Citation>Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification. PLoS One 2020;15(6):e0234682. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292379</ArticleId><ArticleId IdType="pubmed">32530929</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lau 2020 {published data only}</Title><Reference><Citation>Lau YL, Ismail I, Mustapa NI, Lai MY, Tuan Soh TS, Hassan A, et al. Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of SARS-CoV-2. PeerJ 2020;8:e9278. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275676</ArticleId><ArticleId IdType="pubmed">32547882</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lee 2020 {published data only}</Title><Reference><Citation>Lee JYH, Best N, McAuley J, Porter JL, Seemann T, Schultz MB, et al. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA. Journal of Medical Microbiology 2020;69(9):1169-78. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656183</ArticleId><ArticleId IdType="pubmed">32755529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li J 2022 {published data only}</Title><Reference><Citation>Li J, Lin W, Du P, Liu W, Liu X, Yang C, et al. Comparison of reverse-transcription qPCR and droplet digital PCR for the detection of SARS-CoV-2 in clinical specimens of hospitalized patients. Diagnostic Microbiology and Infectious Disease 2022;103(2):115677. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933867</ArticleId><ArticleId IdType="pubmed">35417835</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2020 {published data only}</Title><Reference><Citation>Liu C, Shi Q, Peng M, Lu R, Li H, Cai Y, et al. Evaluation of droplet digital PCR for quantification of SARS-CoV-2 virus in discharged COVID-19 patients. Aging (Albany NY) 2020;12(21):20997-1003. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695381</ArticleId><ArticleId IdType="pubmed">33136068</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu X 2020 {published data only}</Title><Reference><Citation>Liu X, Feng J, Zhang Q, Guo D, Zhang L, Suo T, et al. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets. Emerging Microbes &amp; Infections 2020;9(1):1175-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448863</ArticleId><ArticleId IdType="pubmed">32448084</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lu 2020 {published data only}</Title><Reference><Citation>Lu R, Wu X, Wan Z, Li Y, Jin X, Zhang C. A novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2. International Journal of Molecular Sciences 2020;21(8):2826. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7216271</ArticleId><ArticleId IdType="pubmed">32325642</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lu 2022 {published data only}</Title><Reference><Citation>Lu R, Wang J, Li M, He J, Wang Y, Dong J, et al. Retrospective quantitative detection of SARS-CoV-2 by digital PCR showing high accuracy for low viral load specimens. Journal of Infection in Developing Countries 2022;16(1):10-5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">35192516</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Malta 2021 {published data only}</Title><Reference><Citation>Malta FdM, Amgarten DE, Val FC, Santana RAF, Cervato MC, De Azevedo BMC, et al. Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow. Science Reports 2021;11(1):7122. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007582</ArticleId><ArticleId IdType="pubmed">33782491</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mancini 2020 {published data only}</Title><Reference><Citation>Mancini F, Barbanti F, Scaturro M, Errico G, Iacobino A, Bella A, et al. Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing. Emerging Microbes &amp; Infections 2020;9(1):1393-6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473159</ArticleId><ArticleId IdType="pubmed">32552549</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marchio 2021 {published data only}</Title><Reference><Citation>Marchio A, Batejat C, Vanhomwegen J, Feher M, Grassin Q, Chazal M, et al. ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads. Archives of Virology 2021;166(9):2529-40. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273560</ArticleId><ArticleId IdType="pubmed">34251549</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Méndez 2021 {published data only}</Title><Reference><Citation>Méndez Tibambre ME, Rodríguez Parra ZJ, Portela Dussan DD, Bustamante Restrepo MF, Aristizábal Gutiérrez FA. Método LAMP como alternativa diagnóstica para la detección del virus SARS-CoV-2. Revista Colombiana de Ciencias Químico Farmacéuticas 2021;50(3):633-49.</Citation></Reference></ReferenceList><ReferenceList><Title>Meza‐Robles 2020 {published data only}</Title><Reference><Citation>Meza-Robles C, Barajas-Saucedo CE, Tiburcio-Jimenez D, Mokay-Ramirez KA, Melnikov V, Rodriguez-Sanchez IP, et al. One-step nested RT-PCR for COVID-19 detection: a flexible, locally developed test for SARS-CoV2 nucleic acid detection. Journal of Infection in Developing Countries 2020;14(7):679-84. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32794453</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Michel 2020 {published data only}</Title><Reference><Citation>Michel D, Danzer KM, Gross R, Conzelmann C, Muller JA, Freischmidt A, et al. Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA. Journal of Virological Methods 2020;286:113965. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468345</ArticleId><ArticleId IdType="pubmed">32891677</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Misra 2022 {published data only}</Title><Reference><Citation>Misra CS, Rangu SS, Phulsundar RD, Bindal G, Singh M, Shashidhar R, et al. An improved, simple and field-deployable CRISPR-Cas12a assay for the detection of SARS-CoV-2. Journal of Applied Microbiology 2022;133(4):2668-77. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">35882427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mohon 2020 {published data only}</Title><Reference><Citation>Mohon AN, Oberding L, Hundt J, Van Marle G, Pabbaraju K, Berenger BM, et al. Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2. Journal of Virological Methods 2020;286:113972. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490281</ArticleId><ArticleId IdType="pubmed">32941977</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mokhtar 2020 {published data only}</Title><Reference><Citation>Mokhtar KM. Improved COVID-19 testing by extraction-free SARS-CoV-2 RT-PCR. Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine 2020;31(4):362-8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745296</ArticleId><ArticleId IdType="pubmed">33376476</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moses 2020 {published data only}</Title><Reference><Citation>Moses SE, Warren C, Robinson P, Curtis J, Asquith S, Holme J, et al. Endpoint PCR detection of Sars-CoV-2 RNA. medRxiv 2020;NA:1-16. [DOI: 10.1101/2020.07.21.20158337]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.21.20158337</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Motohashi 2022 {published data only}</Title><Reference><Citation>Motohashi A, Yamamoto K, Mezaki K, Moriya A, Kurokawa M, Oki H, et al. Negative results of nucleic acid amplification tests for SARS-CoV-2 in clinical practice may vary among six molecular assays in patients with COVID-19. Japanese Journal of Infectious Diseases 2022;75(3):309-13. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">34588366</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Naranbat 2022 {published data only}</Title><Reference><Citation>Naranbat D, Schneider L, Kantor R, Beckwith CG, Bazerman L, Gillani F, et al. DirectDetect SARS-CoV-2 Direct Real-Time RT-PCR study using patient samples. ACS Omega 2022;7(6):4945-55. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8845437</ArticleId><ArticleId IdType="pubmed">35187313</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nassir 2020 {published data only}</Title><Reference><Citation>Nassir AA, Baptiste MJ, Mwikarago I, Habimana MR, Ndinkabandi J, Murangwa A, et al. RPA-Based method for the detection of SARS-CoV2. medRxiv 2020;NA:1-23. [DOI: 10.1101/2020.09.17.20196402]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.17.20196402</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Patchsung 2020 {published data only}</Title><Reference><Citation>Patchsung M, Jantarug K, Pattama A, Aphicho K, Suraritdechachai S, Meesawat P, et al. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nature Biomedical Engineering 2020;4(12):1140-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32848209</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pierri 2022 {published data only}</Title><Reference><Citation>Pierri B, Mancusi A, Proroga YTR, Capuano F, Cerino P, Girardi S, et al. SARS-CoV-2 detection in nasopharyngeal swabs: performance characteristics of a real-time RT-qPCR and a droplet digital RT-PCR assay based on the exonuclease region (ORF1b, nsp 14). Journal of Virology Methods 2022;300:114420. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660663</ArticleId><ArticleId IdType="pubmed">34902456</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qian 2020 {published data only}</Title><Reference><Citation>Qian J, Boswell SA, Chidley C, Lu ZX, Pettit ME, Gaudio BL, et al. An enhanced isothermal amplification assay for viral detection. Nature Communications 2020;11(1):5920. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7679446</ArticleId><ArticleId IdType="pubmed">33219228</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ratcliff 2020 {published data only}</Title><Reference><Citation>Ratcliff J, Nguyen D, Andersson M, Simmonds P. Evaluation of different PCR assay formats for sensitive and specific detection of SARS-CoV-2 RNA. bioRxiv 2020;NA:1-16. [DOI: 10.1101/2020.06.24.168013]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.24.168013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rauch 2020 {published data only}</Title><Reference><Citation>Rauch JN, Valois E, Ponce-Rojas JC, Aralis Z, Lach RS, Zappa F, et al. CRISPR-based and RT-qPCR surveillance of SARS-CoV-2 in asymptomatic individuals uncovers a shift in viral prevalence among a university population. medRxiv 2020;NA:1-21. [DOI: 10.1101/2020.08.06.20169771]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.06.20169771</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rauch 2021 {published data only}</Title><Reference><Citation>Rauch JN, Valois E, Ponce-Rojas JC, Aralis Z, Lach RS, Zappa F, et al. Comparison of severe acute respiratory syndrome coronavirus 2 screening using reverse transcriptase-quantitative polymerase chain reaction or CRISPR-based assays in asymptomatic college students. JAMA Network Open 2021;4(2):e2037129. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879237</ArticleId><ArticleId IdType="pubmed">33570576</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rebbapragada 2022 {published data only}</Title><Reference><Citation>Rebbapragada A, Cariazo L, Elchuk D, Abdelrahman H, Pham D, Joseph N, et al. Performance of the Cue COVID-19 Molecular Test for point of care: insights from a multi-site clinic service model. medRxiv 2022;NA:1-25. [DOI: 10.1101/2022.08.12.22278567]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.12.22278567</ArticleId><ArticleId IdType="pmc">PMC10580901</ArticleId><ArticleId IdType="pubmed">37728337</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rodriguez‐Manzano 2021 {published data only}</Title><Reference><Citation>Rodriguez-Manzano J, Malpartida-Cardenas K, Moser N, Pennisi I, Cavuto M, Miglietta L, et al. Handheld point-of-care system for rapid detection of SARS-CoV-2 extracted RNA in under 20 min. ACS Central Science 2021;7(2):307-17. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839415</ArticleId><ArticleId IdType="pubmed">33649735</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sahajpal 2020 {published data only}</Title><Reference><Citation>Sahajpal NS, Mondal AK, Njau A, Ananth S, Kothandaraman A, Hegde M, et al. Clinical validation of innovative, low cost, kit-free, RNA processing protocol for RT-PCR based COVID-19 testing. medRxiv 2020;NA:1-12. [DOI: 10.1101/2020.07.28.20163626]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.28.20163626</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Saluzzo 2021 {published data only}</Title><Reference><Citation>Saluzzo F, Mantegani P, Poletti de Chaurand V, Cugnata F, Rovere-Querini P, Cilla M, et al. Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy. European Respiratory Journal 2021;58(6):2102099. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859976</ArticleId><ArticleId IdType="pubmed">34649973</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schellenberg 2020 {published data only}</Title><Reference><Citation>Schellenberg JJ, Ormond M, Keynan Y. Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples. medRxiv 2020;NA:1-17. [DOI: 10.1101/2020.12.07.20239558]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.07.20239558</ArticleId><ArticleId IdType="pmc">PMC7885624</ArticleId><ArticleId IdType="pubmed">33636553</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schermer 2020 {published data only}</Title><Reference><Citation>Schermer B, Fabretti F, Damagnez M, Di Cristanziano V, Heger E, Arjune S, et al. Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay. PLoS One 2020;15(11):e0238612. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605681</ArticleId><ArticleId IdType="pubmed">33137122</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smyrlaki 2020 {published data only}</Title><Reference><Citation>Smyrlaki I, Ekman M, Lentini A, Rufino de Sousa N, Papanicolaou N, Vondracek M, et al. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nature Communications 2020;11(1):4812. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511968</ArticleId><ArticleId IdType="pubmed">32968075</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Song 2021 {published data only}</Title><Reference><Citation>Song J, El-Tholoth M, Li Y, Graham-Wooten J, Liang Y, Li J, et al. Single- and two-stage, closed-tube, point-of-care, molecular detection of SARS-CoV-2. Analytical Chemistry 2021;93(38):13063. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482318</ArticleId><ArticleId IdType="pubmed">34541844</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Suo 2020 {published data only}</Title><Reference><Citation>Suo T, Liu X, Feng J, Guo M, Hu W, Guo D, et al. DdPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens. Emerging Microbes &amp; Infections 2020;9(1):1259-68. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448897</ArticleId><ArticleId IdType="pubmed">32438868</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tan 2022 {published data only}</Title><Reference><Citation>Tan SYH, Kwek SYM, Low H, Pang YLJ. Absolute quantification of SARS-CoV-2 with Clarity Plus digital PCR. Methods 2022;201:26-33. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339599</ArticleId><ArticleId IdType="pubmed">34273478</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Toppings 2021 {published data only}</Title><Reference><Citation>Toppings NB, Mohon AN, Lee Y, Kumar H, Lee D, Kapoor R, et al. A rapid near-patient detection system for SARS-CoV-2 using saliva. Scientific Reports 2021;11(1):13378. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238998</ArticleId><ArticleId IdType="pubmed">34183720</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ulloa 2020 {published data only}</Title><Reference><Citation>Ulloa S, Bravo C, Parra B, Ramirez E, Acevedo A, Fasce R, et al. A simple method for SARS-CoV-2 detection by rRT-PCR without the use of a commercial RNA extraction kit. Journal of Virological Methods 2020;285:113960. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442555</ArticleId><ArticleId IdType="pubmed">32835738</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Van Nguyen 2022 {published data only}</Title><Reference><Citation>Nguyen Van JC, Pilmis B, Khaterchi A, Billuart O, De Ponfilly GP, Le Monnier A, et al. Organizational impact of an ID NOW COVID-19 point-of-care testing for SARS-CoV2 detection in a maternity ward. medRxiv 2022;NA:1-15. [DOI: 10.1101/2022.08.29.22279161]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.29.22279161</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Van Poelvoorde 2021 {published data only}</Title><Reference><Citation>Van Poelvoorde LAE, Gand M, Fraiture MA, De Keersmaecker SCJ, Verhaegen B, Van Hoorde K, et al. Strategy to develop and evaluate a multiplex RT-ddPCR in response to SARS-CoV-2 genomic evolution. Current Issues in Molecular Biology 2021;43(3):1937-49. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8928932</ArticleId><ArticleId IdType="pubmed">34889894</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang 2020 {published data only}</Title><Reference><Citation>Wang D, He S, Wang X, Yan Y, Liu J, Wu S, et al. Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA. Nature Biomedical Engineering 2020;4(12):1150-8. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">33273714</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang J 2020a {published data only}</Title><Reference><Citation>Wang J, Cai K, Zhang R, He X, Shen X, Liu J, et al. Novel one-step single-tube nested quantitative real-time PCR assay for highly sensitive detection of SARS-CoV-2. Analytical Chemistry 2020;92(13):9399-404. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32438806</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang J 2020b {published data only}</Title><Reference><Citation>Wang J, Cai K, He X, Shen X, Liu J, Xu J, et al. A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA. Clinical Microbiology and Infection 2020;26(8):1076-81. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227500</ArticleId><ArticleId IdType="pubmed">32422410</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang M 2020 {published data only}</Title><Reference><Citation>Wang M, Fu A, Hu B, Tong Y, Liu R, Liu Z, et al. Nanopore targeted sequencing for the accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses. Micro and Nano: No Small Matter 2020;16(32):e2002169. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361204</ArticleId><ArticleId IdType="pubmed">32578378</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang X 2020 {published data only}</Title><Reference><Citation>Wang X, Zhong M, Liu Y, Ma P, Dang L, Meng Q, et al. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER. Science Bulletin (Beijing) 2020;65(17):1436-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198415</ArticleId><ArticleId IdType="pubmed">32373393</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wei F 2020 {published data only}</Title><Reference><Citation>Wei F, Yu Y, Hu Z, Wang R, Guo X, Jin H, et al. Laboratory validation of an RNA/DNA hybrid tagmentation based mNGS workflow on SARS-CoV-2 and other respiratory RNA viruses detection. medRxiv 2020;NA:1-30. [DOI: 10.1101/2020.05.12.20099754]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.12.20099754</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wei S 2021 {published data only}</Title><Reference><Citation>Wei S, Kohl E, Djandji A, Morgan S, Whittier S, Mansukhani M, et al. Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction. Scientific Reports 2021;11(1):2402. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844049</ArticleId><ArticleId IdType="pubmed">33510181</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Woo 2020 {published data only}</Title><Reference><Citation>Woo CH, Jang S, Shin G, Jung GY, Lee JW. Sensitive fluorescence detection of SARS-CoV-2 RNA in clinical samples via one-pot isothermal ligation and transcription. Nature Biomedical Engineering 2020;4(12):1168-79. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499000</ArticleId><ArticleId IdType="pubmed">32948855</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wozniak 2020 {published data only}</Title><Reference><Citation>Wozniak A, Cerda A, Ibarra-Henríquez C, Sebastian V, Armijo G, Lamig L, et al. A simple RNA preparation method for SARS-CoV-2 detection by RT-qPCR. Scientific Reports 2020;10(1):16608. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538882</ArticleId><ArticleId IdType="pubmed">33024174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wu T 2020 {published data only}</Title><Reference><Citation>Wu T, Ge Y, Zhao K, Zhu X, Chen Y, Wu B, et al. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Virology 2020;549:1-4. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388781</ArticleId><ArticleId IdType="pubmed">32758712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xing 2020 {published data only}</Title><Reference><Citation>Xing W, Liu Y, Wang H, Li S, Lin Y, Chen L, et al. A hgh-throughput, multi-index isothermal amplification platform for rapid detection of 19 types of common respiratory viruses including SARS-CoV-2. Engineering (Beijing) 2020;6(10):1130-40. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833526</ArticleId><ArticleId IdType="pubmed">33520332</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xue G 2020 {published data only}</Title><Reference><Citation>Xue G, Li S, Zhang W, Du B, Cui J, Yan C, et al. Reverse-transcription recombinase-aided amplification assay for rapid detection of the 2019 novel coronavirus (SARS-CoV-2). Analytical Chemistry 2020;92(14):9699-705. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32441935</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yan 2020 {published data only}</Title><Reference><Citation>Yan C, Cui J, Huang L, Du B, Chen L, Xue G, et al. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clinical Microbiology and Infection 2020;26(6):773-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144850</ArticleId><ArticleId IdType="pubmed">32276116</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yip 2020 {published data only}</Title><Reference><Citation>Yip CC, Sridhar S, Leung KH, Ng AC, Chan KH, Chan JF, et al. Development and evaluation of novel and highly sensitive single-tube nested real-time RT-PCR assays for SARS-CoV-2 detection. International Journal of Molecular Sciences 2020;21(16):5674. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461039</ArticleId><ArticleId IdType="pubmed">32784770</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yoshimi 2020 {published data only}</Title><Reference><Citation>Yoshimi K, Takeshita K, Yamayoshi S, Shibumura S, Yamauchi Y, Yamamoto M, et al. CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus. iScience 2022;25(2):103830. [DOI: 10.1016/j.isci.2022.103830]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.103830</ArticleId><ArticleId IdType="pmc">PMC8801231</ArticleId><ArticleId IdType="pubmed">35128347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimi K, Takeshita K, Yamayoshi S, Shibumura S, Yamauchi Y, Yamamoto M, et al. Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3. medRxiv 2020;NA:1-30. [DOI: 10.1101/2020.06.02.20119875]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.02.20119875</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2021 {published data only}</Title><Reference><Citation>Zhang Y, Tanner NA. Development of multiplexed reverse-transcription loop-mediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA. Biotechniques 2021;70(3):167-74. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7860930</ArticleId><ArticleId IdType="pubmed">33535813</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhu X 2020 {published data only}</Title><Reference><Citation>Zhu X, Wang X, Han L, Chen T, Wang L, Li H, et al. Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19. Biosensors and Bioelectronics 2020;166:112437. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361114</ArticleId><ArticleId IdType="pubmed">32692666</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>ChiCTR2000029810 {unpublished data only}</Title><Reference><Citation>ChiCTR2000029810. Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein [Development and application of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein ]. chictr.org.cn/showproj.aspx?proj=49407 (first received 14 February 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>CTRI/2021/02/030950 {unpublished data only}</Title><Reference><Citation>CTRI/2021/02/030950. A new test to diagnose COVID-19 [Validation of the TataMD CHECK CRISPR SARS-CoV-2 test 1.0 for the diagnosis of COVID-19 ]. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52209 (first received 03 February 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>Fokam 2022 {published data only}</Title><Reference><Citation>Fokam J, Alteri C, Colagrossi L, Genevieve AM, Takou D, Ndjolo A, et al. Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: the EDCTP "PERFECT-study" protocol (RIA2020EF-3000). PLoS One 2022;17(9):e0273818. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491536</ArticleId><ArticleId IdType="pubmed">36129931</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT04367545 {unpublished data only}</Title><Reference><Citation>NCT04367545. Development of a molecular diagnostic strategy for SARS-CoV2 based on saliva in the context of the COVID-19 pandemic (MolCOVID) [Development of a molecular diagnostic strategy for SARS-CoV2 based on saliva in the context of the COVID-19 pandemic]. clinicaltrials.gov/ct2/show/NCT04367545 (first received 29 April 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04510454 {unpublished data only}</Title><Reference><Citation>NCT04510454. Evaluation of a ddPCR technology for the SARS-CoV-2 detection in symptomatic patients with suspicion of COVID-19 (ONCOVID-21) [Evaluation of a ddPCR technology for the SARS-CoV-2 detection in symptomatic patients with suspicion of COVID-19]. clinicaltrials.gov/ct2/show/NCT04510454 (first received 12 August 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04625257 {unpublished data only}</Title><Reference><Citation>NCT04625257. COVID-19 in Baselland: validation of simple and accurate tests for COVID-19 detection, monitoring and tracing (ACCURATE-BL-COVID-19) [COVID-19 in Baselland: validation of simple and accurate tests for COVID-19 detection, monitoring and tracing (ACCURATE-BL-COVID-19)]. clinicaltrials.gov/ct2/show/NCT04625257 (first received 12 November 2020).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Arevalo‐Rodriguez 2020</Title><Reference><Citation>Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, Zambrano-Achig P, Del Campo R, Ciapponi A, et al. False-negative results of initial RT-PCR assays for COVID-19: a systematic review. PLoS One 2020;15(12):e0242958. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728293</ArticleId><ArticleId IdType="pubmed">33301459</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Behera 2021</Title><Reference><Citation>Behera BC, Mishra RR, Thatoi H. Recent biotechnological tools for diagnosis of corona virus disease: a review. Biotechnology Progress 2021;37(1):e3078. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32902193</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bhatt 2022</Title><Reference><Citation>Akansha B, Singh BG, Munindra R, Saif H, Zeeshan F. Diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technique for COVID-19: a systematic review and meta-analysis. Pathogens and Global Health 2022;116(7):410-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862172</ArticleId><ArticleId IdType="pubmed">35142264</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bolotin 2005</Title><Reference><Citation>Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 2005;151(8):2551-61. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16079334</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bossuyt 2015</Title><Reference><Citation>Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. British Medical Journal 2015;351:h5527. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4623764</ArticleId><ArticleId IdType="pubmed">26511519</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bustin 2005</Title><Reference><Citation>Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clinical Science (London) 2005;109:365-79. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16171460</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cartwright 1994</Title><Reference><Citation>Cartwright CP. Techniques and diagnostic applications of in vitro nucleic-acid amplification. Clinical Microbiology Newsletter 1994;16:33-40. [DOI: 10.1016/0196-4399(94)90039-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0196-4399(94)90039-6</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Caruana 2020</Title><Reference><Citation>Caruana G, Croxatto A, Coste AT, Opota O, Lamoth F, Jaton K, et al. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clinical Microbiology and Infection 2020;26(9):1178-82. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315992</ArticleId><ArticleId IdType="pubmed">32593741</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Castellanos‐Gonzalez 2021</Title><Reference><Citation>Castellanos-Gonzalez A, Shelite TR, Lloyd N, Sadiqova A, Ping R, Williams-Bouyer N, et al. Direct RT-PCR amplification of SARS-CoV-2 from clinical samples using a concentrated viral lysis-amplification buffer prepared with IGEPAL-630. Scientific Reports 2021;11(1):14204. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270935</ArticleId><ArticleId IdType="pubmed">34244543</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clopper 1934</Title><Reference><Citation>Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26(4):404-413.</Citation></Reference></ReferenceList><ReferenceList><Title>Corman 2020</Title><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 2020;25(3):2000045. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Covidence [Computer program]</Title><Reference><Citation>Covidence. Veritas Health Innovation, (accessed 20 October 2021). Available at covidence.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Darnell 2004</Title><Reference><Citation>Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. Journal of Virology Methods 2004;121(1):85-91. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112912</ArticleId><ArticleId IdType="pubmed">15350737</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2020</Title><Reference><Citation>Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, Spijker R, et al. Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers. Cochrane Database of Systematic Reviews 2020, Issue 6. Art. No: CD013596. [DOI: 10.1002/14651858.CD013596]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013596</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Deeks 2020a</Title><Reference><Citation>Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database of Systematic Reviews 2020, Issue 6. Art. No: CD013652. [DOI: 10.1002/14651858.CD013652] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013652</ArticleId><ArticleId IdType="pmc">PMC7387103</ArticleId><ArticleId IdType="pubmed">32584464</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dinnes 2021</Title><Reference><Citation>Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database of Systematic Reviews 2021, Issue 3. Art. No: CD013705. [DOI: 10.1002/14651858.CD013705] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013705</ArticleId><ArticleId IdType="pmc">PMC8078597</ArticleId><ArticleId IdType="pubmed">33760236</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dinnes 2022</Title><Reference><Citation>Dinnes J, Sharma P, Berhane S, Van Wyk SS, Nyaaba N, Domen J, et al. Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database of Systematic Reviews 2022, Issue 7. Art. No: CD013705. [DOI: 10.1002/14651858.CD013705.pub3] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013705.pub3</ArticleId><ArticleId IdType="pmc">PMC9305720</ArticleId><ArticleId IdType="pubmed">35866452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dorlass 2020</Title><Reference><Citation>Dorlass EG, Monteiro CO, Viana AO, Soares CP, Machado RRG, Thomazelli LM, et al. Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR. Brazilian Journal of Microbiology 2020;51(3):1117-23. [DOI: 10.1007/s42770-020-00347-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42770-020-00347-5</ArticleId><ArticleId IdType="pmc">PMC7411266</ArticleId><ArticleId IdType="pubmed">32767275</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>El Jaddaoui 2021</Title><Reference><Citation>El Jaddaoui I, Allali M, Raoui S, Sehli S, Habib N, Chaouni B, et al. A review on current diagnostic techniques for COVID-19. Expert Review of Molecular Diagnostics 2021;21(2):141-60. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">33593219</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esbin 2020</Title><Reference><Citation>Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 2020;26(7):771-83. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297120</ArticleId><ArticleId IdType="pubmed">32358057</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>EUnetHTA 2020</Title><Reference><Citation>EUnetHTA RCRC02 Authoring Team. The diagnostic accuracy of molecular methods that detect the presence of the SARS-CoV-2 virus in people with suspected COVID-19. www.eunethta.eu/wp-content/uploads/2021/03/Project_Plan_RCROT02_Molecular_Methods_08102020-1.pdf?x50316 (accessed prior to 19 Sept 2024).</Citation></Reference></ReferenceList><ReferenceList><Title>Fox 2022</Title><Reference><Citation>Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2. Cochrane Database of Systematic Reviews 2022, Issue 11. Art. No: CD013652. [DOI: 10.1002/14651858.CD013652.pub2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013652.pub2</ArticleId><ArticleId IdType="pmc">PMC9671206</ArticleId><ArticleId IdType="pubmed">36394900</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fraga 2014</Title><Reference><Citation>Fraga D, Meulia T, Fenster S. Real-time PCR. Current Protocols Essential Laboratory Techniques 2014;8(1):10.3.1-10.3.40. [DOI: 10.1002/9780470089941.et1003s08]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470089941.et1003s08</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Freeman 1999</Title><Reference><Citation>Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. BioTechniques 1999;26(1):112-25. [DOI: 10.2144/99261rv01]</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/99261rv01</ArticleId><ArticleId IdType="pubmed">9894600</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ganbaatar 2021</Title><Reference><Citation>Ganbaatar U, Liu C. CRISPR-Based COVID-19 testing: toward next-generation point-of-care diagnostics. Frontiers in Cellular and Infection Microbiology 2021;11:663949. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120276</ArticleId><ArticleId IdType="pubmed">33996635</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gibson 1996</Title><Reference><Citation>Gibson UEM, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Research 1996;6:995-1001. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8908519</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Healy 2021</Title><Reference><Citation>Healy B, Khan A, Metezai H, Blyth I, Asad H. The impact of false positive COVID-19 results in an area of low prevalence. Clinical Medicine (London) 2021;21(1):e54-6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850182</ArticleId><ArticleId IdType="pubmed">33243836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hill 2001</Title><Reference><Citation>Hill CS. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Review of Molecular Diagnostics 2001;1(4):445-55. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11901859</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hille 2018</Title><Reference><Citation>Hille F, Richter H, Wong SP, Bratovič M, Ressel S, Charpentier E. The biology of CRISPR-Cas: backward and forward. Cell 2018;172(6):1239-59. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">29522745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hindson 2013</Title><Reference><Citation>Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nature Methods 2013;10(10):1003-5. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4118677</ArticleId><ArticleId IdType="pubmed">23995387</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huggett 2021</Title><Reference><Citation>Huggett JF, Moran-Gilad J, Lee JE. COVID-19 new diagnostics development: novel detection methods for SARS-CoV-2 infection and considerations for their translation to routine use. Current Opinion in Pulmonar Medicine 2021;27(3):155-62. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">33654014</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jaffe 2001</Title><Reference><Citation>Jaffe RI, Lane JD, Bates CW. Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J Clin Lab Anal 2001;15(3):131-7. [DOI: 10.1002/jcla.1016]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.1016</ArticleId><ArticleId IdType="pmc">PMC6807775</ArticleId><ArticleId IdType="pubmed">11344528</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>James 2015</Title><Reference><Citation>James A, Macdonald J. Recombinase polymerase amplification: emergence as a critical molecular technology for rapid, low-resource diagnostics. Expert Review of Molecular Diagnostics 2015;15(11):1475-89. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">26517245</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>James 2020</Title><Reference><Citation>James AS, Alawneh JI. COVID-19 infection diagnosis: potential impact of isothermal amplification technology to reduce community transmission of SARS-CoV-2. Diagnostics (Basel) 2020;10(6):399. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7345291</ArticleId><ArticleId IdType="pubmed">32545412</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jarvis 2021</Title><Reference><Citation>Jarvis KF, Kelley JB. Temporal dynamics of viral load and false negative rate influence the levels of testing necessary to combat COVID-19 spread. Scientific Reports 2021;11(1):9221. [DOI: 10.1038/s41598-021-88498-9]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88498-9</ArticleId><ArticleId IdType="pmc">PMC8080800</ArticleId><ArticleId IdType="pubmed">33911131</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kelly‐Cirino 2019</Title><Reference><Citation>Kelly-Cirino C, Mazzola LT, Chua A, Oxenford CJ, Van Kerkhove MD. An updated roadmap for MERS-CoV research and product development: focus on diagnostics. BMJ Global Health 2019;4(Suppl 2):e001105. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361340</ArticleId><ArticleId IdType="pubmed">30815285</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khare 2021</Title><Reference><Citation>Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. GISAID's role in pandemic response. China CDC Wkly 2021;3(49):1049-51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kucirka 2020</Title><Reference><Citation>Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Annals of Internal Medicine 2020;173(4):262-7. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kwoh 1990</Title><Reference><Citation>Kwoh DY, Kwoh TJ. Target amplification systems in nucleic acid-based diagnostic approaches. American Biotechnology Laboratory 1990;8(13):14-25. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1370001</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lai 2021</Title><Reference><Citation>Lai CKC, Lam W. Laboratory testing for the diagnosis of COVID-19. Biochemical and Biophysical Research Communications 2021;538:226-30. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598306</ArticleId><ArticleId IdType="pubmed">33139015</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Leeflang 2013</Title><Reference><Citation>Leeflang MM, Rutjes AW, Reitsma JB, Hooft L, Bossuyt PM. Variation of a test's sensitivity and specificity with disease prevalence. Canadian Medical Association Journal 2013;185(11):E537-44. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3735771</ArticleId><ArticleId IdType="pubmed">23798453</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2018</Title><Reference><Citation>Li H, Bai R, Zhao Z, Tao L, Ma M, Ji Z, et al. Application of droplet digital PCR to detect the pathogens of infectious diseases. Bioscience Reports 2018;38(6):BSR20181170. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240714</ArticleId><ArticleId IdType="pubmed">30341241</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2018a</Title><Reference><Citation>Li J, Macdonald J, Von Stetten F. Review: a comprehensive summary of a decade development of the recombinase polymerase amplification. Analyst 2018;144(1):31-67. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">30426974</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2019</Title><Reference><Citation>Li Y, Li S, Wang J, Liu G. CRISPR/Cas systems towards next-generation biosensing. Trends in Biotechnology 2019;37(7):730-43. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">30654914</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mackay 2004</Title><Reference><Citation>Mackay IM. Real-time PCR in the microbiology laboratory. Clinical Microbiology and Infection 2004;10:190-212. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15008940</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Manoj 2016</Title><Reference><Citation>Manoj P. Droplet digital PCR technology promises new applications and research areas. Mitochondrial DNA Part A 2016;27(1):742-6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24779593</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mayers 2020</Title><Reference><Citation>Mayers C, Baker K. Impact of false positives and negatives. www.gov.uk/government/publications/gos-impact-of-false-positives-and-negatives-3-june-2020 (accessed prior to 19 Sept 2024). [assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895843/S0519_Impact_of_false_positives_and_negatives.pdf]</Citation></Reference></ReferenceList><ReferenceList><Title>Mitchell 2020</Title><Reference><Citation>Mitchell SL, St George K, Rhoads DD, Butler-Wu SM, Dharmarha V, McNult P, et al. Understanding, verifying, and implementing emergency use authorization molecular diagnostics for the detection of SARS-CoV-2 RNA. Journal of Clinical Microbiology 2020;58(8):e00796-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383533</ArticleId><ArticleId IdType="pubmed">32381642</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Morrison 1998</Title><Reference><Citation>Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954-62. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9631186</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mullis 1986</Title><Reference><Citation>Mullis K, Faloona F, Scharf S, Saiki R, Horn G. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symposia on Quantitative Biology 1986;51(1):263-73. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3472723</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ngo 2017</Title><Reference><Citation>Ngo KA, Jones SA, Church TM, Fuschino ME, George KSt, Lamson DM, et al. Unreliable inactivation of viruses by commonly used lysis buffers. Applied Biosafety 2017;22(2):56-9. [DOI: 10.1177/1535676017703383]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535676017703383</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Notomi 2000</Title><Reference><Citation>Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Research 2000;28(12):E63. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102748</ArticleId><ArticleId IdType="pubmed">10871386</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nyaruaba 2019</Title><Reference><Citation>Nyaruaba R, Mwaliko C, Kering KK, Wei H. Droplet digital PCR applications in the tuberculosis world. Tuberculosis 2019;117:85-92. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">31378274</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ortiz‐Prado 2020</Title><Reference><Citation>Ortiz-Prado E, Simbaña-Rivera K, Gómez- Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagnostic Microbiology and Infectious Disease 2020;98(1):115094. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260568</ArticleId><ArticleId IdType="pubmed">32623267</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Piepenburg 2006</Title><Reference><Citation>Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biology 2006;4(7):e204. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1475771</ArticleId><ArticleId IdType="pubmed">16756388</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Plana 2022</Title><Reference><Citation>Plana MN, Arevalo-Rodriguez I, Fernández-García S, Soto J, Fabregate M, Pérez T, et al. Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data. BMC Medical Research Methodology 2022;22(1):306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9707040</ArticleId><ArticleId IdType="pubmed">36443653</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qi 2020</Title><Reference><Citation>Qi C, Zhenyun H, Fujing M, Hua P, Hongmei C, Xing L. Diagnostic technologies for COVID-19: a review. RSC Advances 2020;10(58):35257-64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9056975</ArticleId><ArticleId IdType="pubmed">35515699</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rutjes 2007</Title><Reference><Citation>Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technology Assessment 2007;11(50):iii, ix-51. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18021577</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Safiabadi 2021</Title><Reference><Citation>Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clinical Microbiology Reviews 2021;34(3):e00228-20. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142517</ArticleId><ArticleId IdType="pubmed">33980687</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Saiki 1985</Title><Reference><Citation>Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Biotechnology 1985;24:476-80. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1422056</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Struyf 2022</Title><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No: CD013665. [DOI: 10.1002/14651858.CD013665.pub3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013665.pub3</ArticleId><ArticleId IdType="pmc">PMC9121352</ArticleId><ArticleId IdType="pubmed">35593186</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Subali 2021</Title><Reference><Citation>Subali AD, Wiyono L. Reverse transcriptase loop mediated isothermal amplification (RT-LAMP) for COVID-19 diagnosis: a systematic review and meta-analysis. Pathogens and Global Health 2021;6:1-11. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182821</ArticleId><ArticleId IdType="pubmed">34086539</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sykes 1992</Title><Reference><Citation>Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA. Quantitation of targets for PCR by use of limiting dilution. Biotechniques 1992;13(3):444-9. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1389177</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Takwoingi 2023</Title><Reference><Citation>Takwoingi Y, Dendukuri N, Schiller I, Rücker G, Jones HE, Partlett C, et al. Chapter 10: Undertaking meta-analysis. In: Deeks, JJ, Bossuyt, PM, Leeflang, MM, Takwoingi Y, editors(s). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. 1 edition. Chichester (UK): John Wiley &amp; Sons, 2023.</Citation></Reference></ReferenceList><ReferenceList><Title>Takwoingi 2023a</Title><Reference><Citation>Takwoingi Y, Dendukuri N, Schiller I, Rücker G, Jones HE, Partlett C, et al. Supplementary material 1 to Chapter 10: Code for undertaking meta-analysis. In: Deeks, JJ, Bossuyt, PM, Leeflang, MM, Takwoingi Y, editors(s). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. 1 edition. London: John Wiley &amp; Sons Ltd, 2023.</Citation></Reference></ReferenceList><ReferenceList><Title>Umemneku 2019</Title><Reference><Citation>Umemneku Chikere CM, Wilson K, Graziadio S, Vale L, Allen AJ. Diagnostic test evaluation methodology: a systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - an update. PLoS One 2019;14(10):e0223832. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788703</ArticleId><ArticleId IdType="pubmed">31603953</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Umubyeyi 2022</Title><Reference><Citation>Umubyeyi NA, Scholten JN, Gidado M, Suarez PG. Coronavirus disease 2019 diagnosis in low- and middle-income countries: the big new bully disrupting TB and HIV diagnostic services. Journal of Molecular Diagnostics 2022;24(4):289-93. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810266</ArticleId><ArticleId IdType="pubmed">35123038</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Usher‐Smith 2016</Title><Reference><Citation>Usher-Smith JA, Sharp SJ, Griffin SJ. The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ 2016;353:i3139. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4916916</ArticleId><ArticleId IdType="pubmed">27334281</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Whiting 2011</Title><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2020</Title><Reference><Citation>World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance. www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2 (accessed prior to 19 Sept 2024).</Citation></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2021a</Title><Reference><Citation>World Health Organization. Living guidance for clinical management of COVID-19. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 (accessed prior to 19 Sept 2024). [LICENCE: CC BYNC-SA 3.0 IGO l]</Citation></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2021b</Title><Reference><Citation>World Health Organization. Overview of the WHO prequalification of in vitro diagnostics assessment: prequalification of in vitro diagnostics. Version 9. https://apps.who.int/iris/handle/10665/259403 (accessed prior to 19 Sept 2024). [LICENCE: CC BY-NC-SA 3.0 IGO]</Citation></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2021c</Title><Reference><Citation>World Health Organization. Technical specifications for selection of essential in vitro diagnostics for SARS-COV-2 [Technical specifications for selection of essential in vitro diagnostics for SARS-COV-2]. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Essential_IVDs-2021.1 (accessed prior to 19 Sept 2024):31.</Citation></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2023a</Title><Reference><Citation>International Health Regulations (2005) (IHR) Emergency Committee. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic (accessed prior to 19 Sept 2024).</Citation></Reference></ReferenceList><ReferenceList><Title>World Health Organization 2023b</Title><Reference><Citation>World Health Organization. Coronavirus disease (COVID-19) pandemic — emergency use listing procedure (EUL) for IVDs. https://extranet.who.int/pqweb/vitro-diagnostics/coronavirus-disease-covid-19-pandemic-%E2%80%94-emergency-use-listing-procedure-eul-open (accessed prior to 19 Sept 2024).</Citation></Reference></ReferenceList><ReferenceList><Title>Zhang 2017</Title><Reference><Citation>Zhang X, Guo L, Ma R, Cong L, Wu Z, Wei Y, et al. Rapid detection of salmonella with recombinase aided amplification. Journal of Microbiological Methods 2017;139:202-4. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">28619662</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhu 2020</Title><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 2020;382(8):727-33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle>